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Abstract
Silica nanoparticles (SNPs) are produced on an industrial scale and are an addition to a growing number of com-
mercial products. SNPs also have great potential for a variety of diagnostic and therapeutic applications in medi-
cine. Contrary to the well-studied crystalline micron-sized silica, relatively little information exists on the toxicity of
its amorphous and nano-size forms. Because nanoparticles possess novel properties, kinetics and unusual bioactiv-
ity, their potential biological effects may differ greatly from those of micron-size bulk materials. In this review, we
summarize the physico-chemical properties of the different nano-sized silica materials that can affect their interac-
tion with biological systems, with a specific emphasis on inhalation exposure. We discuss recent in vitro and in vivo
investigations into the toxicity of nanosilica, both crystalline and amorphous. Most of the in vitro studies of SNPs
report results of cellular uptake, size- and dose-dependent cytotoxicity, increased reactive oxygen species levels
and pro-inflammatory stimulation. Evidence from a limited number of in vivo studies demonstrates largely reversi-
ble lung inflammation, granuloma formation and focal emphysema, with no progressive lung fibrosis. Clearly, more
research with standardized materials is needed to enable comparison of experimental data for the different forms
of nanosilicas and to establish which physico-chemical properties are responsible for the observed toxicity of SNPs.
Introduction
Over the past decade, the definition of nanoparticles has
been controversial. Nanoparticles are commonly
defined as objects with a diameter less than 100 nm, but
no clear size cut-off exists, and this usual boundary does
not appear to have a solid scientific basis. Other defini-
tions of nanoparticles have been proposed, and the most
recent proposal [1] is based on surface area rather than
size (a nanoparticle should have specific surface area >
60 m
2/cm
3), thus reflecting the critical importance of
this parameter in governing the reactivity and toxicity of
nanomaterials. Physico-chemical properties that may be
important in understanding the toxic effects of nanoma-
terials include primary particle size, agglomeration/
aggregation state, size distribution, shape, crystal struc-
ture, chemical composition, surface chemistry, surface
charge, and porosity. Aspects of these properties have
been discussed in several reviews of nanotoxicology
[2-4].
Silica is the common name for materials composed of
silicon dioxide (SiO2) and occurs in crystalline and
amorphous forms. Crystalline silica exists in multiple
forms. Quartz, and more specifically a-quartz is a wide-
spread and well-known material. Upon heating, a-quartz
is transformed into b-quartz, trydimite and cristobalite.
Porosil is the family name for porous crystalline silica.
Quartz exists in natural and synthetic forms, whereas all
porosils are synthetic. Amorphous silica can be divided
into natural specimens (e.g., diatomaceous earth, opal
and silica glass) and human-made products.
The application of synthetic amorphous silica, espe-
cially silica nanoparticles (SNPs), has received wide
attention in a variety of industries. SNPs are produced
on an industrial scale as additives to cosmetics, drugs,
printer toners, varnishes, and food. In addition, nanosi-
lica is being developed for a host of biomedical and
biotechnological applications such as cancer therapy,
DNA transfection, drug delivery, and enzyme immobili-
zation [5-9]. Barik et al. [10] recently reviewed the
impact of nanosilica on basic biology, medicine, and
agro-nanoproducts. With the growing commercialization
of nanotechnology products, human exposure to SNPs is
increasing, and many aspects related to the size of these
nanomaterials have raised concerns about safety [11].
Until recently, most research has focused on silica parti-
cles 0.5 to 10 μm, mainly in crystalline forms, but nano-
silica may have different toxicological properties as
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chemical properties of nano-sized silica that make them
attractive for industry may present potential hazards to
human health, including an enhanced ability to pene-
trate intracellular targets in the lung and systemic
circulation.
Biocompatibility is a critical issue for the industrial
development of nanoparticles [12,13]. Even though no
acute cytotoxicity has been observed or reported, the
uptake of the nanoparticles by cells may eventually lead
to perturbation of intracellular mechanisms. The ability
of silica-coated nanomaterials to penetrate the blood-
brain barrier also strongly suggests that extensive studies
are required to clarify the potential chronic toxicity of
these materials [14].
A number of SNPs have recently been shown to cause
adverse health effects in vitro and in vivo (discussed
later in this review). However, most of the studies have
used poorly characterized particles in terms of their
composition and physico-chemical properties. The dis-
tinct physico-chemical properties of nanoparticles
indeed determine their interaction with the cell/within
the cell, and even subtle differences in such properties
can modulate the toxicity and modes of action. The
results of toxicity studies then become difficult to inter-
pret and compare, and, as a result, drawing appropriate
conclusions is nearly impossible. Although SNPs could
certainly provide benefits to society, their interaction
with biological systems and potential toxic effects must
be carefully addressed.
In this review, we discuss silica materials with a
special attention to the physico-chemical properties
that can affect their potential interaction with biologi-
cal systems. We aim to provide an overview of the
recent in vitro and in vivo investigations of the toxi-
city of nanosilica, both in crystalline and amorphous
forms, rather than review the toxicity of micron-sized
silica and quartz. A summary of the present knowl-
edge on the potential toxic effects of nano-sized silica
particles is needed, because their toxicological pattern
appears distinct from that of micron-sized silica
particles.
Synthesis & Characterization of Silica Materials
Classification of natural and synthetic silica materials
“Silica” is the name given to materials with the chemical
formula of silicon dioxide, SiO2. Silicas can be amor-
phous or crystalline, porous or non-porous (dense),
anhydrous or hydroxylated [15], regardless of their nat-
ural or synthetic nature. In a silica material, the silicon
atom is in tetrahedral coordination with 4 oxygen
atoms. Theoretically, an infinite variety of 3-D-ordered
structures can be built from oxygen-sharing silicate tet-
rahedra. The number of known crystalline silica
materials is limited, which leaves much room for
research and development. In amorphous silica, the tet-
rahedra are randomly connected.
In nature, amorphous silica can have different origins.
Silica can be condensed from vapors emitted in volcanic
eruptions. Natural silica can also be deposited from
supersaturated natural water or polymerized in living
organisms (biogenic silica).T h e s ea m o r p h o u sb i o g e n i c
silicas can be found as isolated particles, skeletal struc-
tures or surface elements in different living organisms.
Many microcrystalline silica minerals such as flint, chert
and chalcedony are derived from biogenic silica after
crystallization by compaction. Kieselguhr (diatomaceous
earth) occurs at various stages of transformation [15]
and therefore often exhibits both crystalline and amor-
phous silica constituents.
Physico-chemical characteristics of synthetic silica
materials related to toxicity
The silica materials presenting a toxicological hazard to
human health are mainly synthetic materials and natural
quartz. The physico-chemical properties of silica materi-
als largely depend on the synthetic procedures used for
their preparation. Therefore, we will briefly discuss silica
synthesis processes.
Silica synthesis
Silica is mainly synthesized from an aqueous solution,
with dissociated monomeric silicic acid, Si(OH)4,o r
from a vapor of a silicon compound such as silicon
tetrachloride.
Waterglass is a concentrated alkaline sodium silicate
solution with anhydrous composition corresponding to
Na2SiO3. It is the most common reagent for silica produc-
tion in aqueous solution. Waterglass is a sodium salt of
silicic acid that forms silicic acid upon acidification. When
the concentration of Si(OH)4 exceeds about 2.10
-3 M, con-
densation to polysilicic acids (Figure 1) occurs, thus lead-
ing to the formation of colloidal silica particles [15].
The polymerization and the formation of silica can be
represented as follows:
[SinO2n-nx/2(OH)nx] + m Si(OH)4 ®
[Sin+mO2n-nx/2+2m(2-p)(OH)nx+4(m-p)]+2p mH 2O
Where:
n = number of silicon atoms in a polysilicic acid
molecule or particle,
x = number of OH groups per silicon atom in the
polymer (0≤ × ≤ 3),
m = number of monomeric silicic acid molecules
added to the polymer, and
p = fraction of the hydroxyl groups per monomeric
silicic acid molecule that are converted to water dur-
ing the polymerization reaction [15].
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tion of monomers in the aqueous solution supersatu-
rated with silicic acid. Various silica materials are
produced in liquid phase processes (Figure 2).
Colloidal silica or silica sol is most often produced in
a multi-step process in which the alkaline silicate
solution is partially neutralized with a mineral acid.
Alternatively, this pH neutralization can be achieved by
electrodialysis. The resulting silica suspension is stabi-
lized by pH adjustment. Finally a solid concentration up
to 50 wt% is reached by water evaporation. Silica sol
nanoparticles show a perfect spherical shape and identi-
cal size as a result of extensive Ostwald ripening [15].
Stöber silica sol is prepared by controlled hydrolysis
and condensation of tetraethylorthosilicate (TEOS) in
ethanol to which catalytic amounts of water and ammo-
nia are added. The Stöber procedure can be used to
obtain monodisperse spherical amorphous silica parti-
cles with tunable size and porosity [16].
Silica gel is obtained by destabilizing silica sol. Silica
g e li sa no p e n3 - Dn e t w o r ko fa g g r e g a t e ds o lp a r t i c l e s .
The pore size is related to the size of the original silica
sol particles composing the gel.
Precipitated silica is formed when a sol is destabi-
lized and precipitated.
Ordered mesoporous silica is obtained by a supra-
molecular assembly of silica around surfactant micelles.
Typical surfactant molecules are amphiphilic polymers
such as tribloc copolymers or quaternary alkylammo-
nium compounds. These organic supramolecular tem-
plates are evacuated from the mesopores, typically via a
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Figure 1 Polymerization of silicic acid molecules through
formation of siloxane bond and water.
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Figure 2 General scheme of silica synthesis processes. Adapted and complemented from [177].
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Page 3 of 32calcination step. Calcination is a controlled combustion
process leading to oxidation and decomposition of the
template molecules into small volatile products such as
NOx,C O 2 and H2O, which can leave the pores. The dia-
meter of the mesopores (2-50 nm) is determined by the
type of surfactant applied [17,18].
A completely different synthesis route of amorphous
silica starts from SiCl4 in the vapor phase. Silicon tetra-
chloride is oxidized in a hydrogen flame at temperatures
exceeding 1000°C and polymerized into amorphous
non-porous SNPs. This nanopowder has very low bulk
density and high specific surface area, typically 200 to
300 m
2/g. This material is called pyrogenic or fumed
silica, referring to the special synthesis conditions [15].
The synthesis of dense crystalline silica such as quartz
from aqueous solution is a slow process requiring heat-
ing the solution to accelerate the formation process in a
so-called hydrothermal synthesis [15]. Alternatively,
under high pressure, amorphous silica can be trans-
formed to crystalline material by microcrystallization.
The appearance of quartz ranges from macroscopic
crystals to microcrystalline powders. Large crystals are
grown at high temperature and pressure in industry.
Smaller quartz crystals are conveniently obtained by
grinding large crystals. Alpha-quartz is formed under
moderate temperature and pressure conditions and is
the most abundant form of quartz. At temperatures
exceeding 573°C, a-quartz can transform into b-quartz
[19]. At atmospheric pressure and temperatures higher
than 870°C, quartz is transformed into tridymite and at
temperatures more than 1470°C into cristobalite [15,20].
These high-temperature polymorphs of quartz have
the same elemental composition but a different
crystal structure and can persist metastably at lower
temperatures.
Dense and porous crystalline materials can be distin-
guished by framework density. The framework density is
conveniently defined as the number of tetrahedrally
coordinated atoms (T-atoms) per nm
3. For dense struc-
tures, such as quartz, tridymite and cristobalite, values
of 22 to 29 T-atoms/nm
3 are common, whereas for por-
osils belonging to the zeolite material family, as few as
12.1 T-atoms/nm
3 are present [21]. The framework
structure of a porosil is denoted with a 3-letter code.
Descriptions are available in the Atlas of Zeolite Frame-
work Types [22].
Porosils are crystallized in aqueous media in the pre-
sence of organic molecules that act as porogens or tem-
plate molecules defining the size and shape of the pores.
Their evacuation is typically achieved through calcina-
tion. Among the porosils are clathrasils and zeosils
[23,24]. Zeosils have cages with windows or channels of
a sufficiently free dimension to allow molecules to diffuse
in and out, a property known as molecular sieving [25].
Clathrasils have cages with windows that are delineated
with a 6-membered ring of SiO units, thus presenting a
free aperture of barely 0.28 nm. Even a molecule as small
as oxygen has no access to the cavities of a clathrasil. The
organic template molecules engaged in the crystallization
of a clathrasil cannot be removed easily from the pores
[23,24].
When heated above 1700°C, any type of silica (amor-
phous or crystalline) melts. During cooling, the disor-
dered structure is solidified, and a dense amorphous
silica glass or vitreous silica is formed [15].
Physico-chemical properties
The properties of silica materials considered essential
for their potential toxicity are crystallinity, particle size
and morphology, porosity, chemical purity, surface
chemistry and solubility [26]. An overview of the prop-
erties of silica materials involved in silica toxicity is pro-
vided in Table 1.
Crystallinity
In crystalline structures such as quartz and porosils, the
arrangement of atoms is ordered in all dimensions.
According to the International Union of Pure and
Applied Chemistry (IUPAC), the atoms must be
arranged periodically with long-range order (at least 10
repeats in all directions) and produce sharp maxima in a
diffraction experiment to observe x-ray diffraction
(XRD) crystallinity [27]. The threshold for observing
crystallinity depends on the unit cell size (size of the
repeated unit in a crystal). For materials with large unit
cells, such as porosils, the minimum particle size
required is about 10 nanometers to observe a distinct,
sharp XRD pattern. Amorphous silica may present some
short-range order but lacks long-range order in 3
dimensions and does not exhibit a sharp XRD pattern.
Of note, the surface of a crystal represents a discontinu-
ity that can be seen as a defect. With the presence of a
less-structured or even partially amorphous rim, crystals
may behave like amorphous particles. Thus, particles
with an ordering at limited-length scales or with amor-
phous regions may be classified as amorphous.
Particle size and morphology
Nanoparticles are obtained by direct synthesis of silica
sol [15] or by crystallization of nano-sized crystals of
quartz or porosils [25]. The particle size is determined
by the synthesis parameters. Amorphous silica sol parti-
cles tend to adopt the spherical shape so as to reach a
minimum of interfacial surface area. The particle size of
commercial silica sols prepared from sodium silicate is
from 10 to 25 nm (Figure 3 left). Sols with larger pri-
mary particles can be prepared from TEOS by Stöber
synthesis, for example (Figure 3 middle). Grinding and
milling processes reduce particle size. These techniques
are most often applied to quartz, silica gel and vitreous
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Page 4 of 32Table 1 Overview of silica materials and relevant properties
Material Nature
of
product
Crystallinity Particle size Porosity Polarity Purity Applications Ref
Colloidal
silica
Sol Amorphous 1-1000 nm Dense Hydrophillic Very
high
Binders, ink [15]
Stober silica Sol Amorphous 10-1000 nm Tunable porosity Hydrophillic Very
high
Research [16]
Precipitated
silica
Powder Amorphous 5-6 nm primary particles precipitated
to 500 nm - 50 μm aggregates
Tunable porosity Hydrophillic Very
high
Filler
and
performance
additive
[15]
Silica gel Powder Amorphous 0.5 – 5 nm primary particles gelled
to networks and milled to 500 μm-
6 mm aggregates
Tunable, void
spaces between
primary particles
Hydrophillic Very
high
Dessicant,
filler
and
performance
additive
[15]
Mesoporous
silica
Powder Amorphous 50 – 1000 nm, aggregated because
of calcinations
Mesoporous Hydrophobic Very
high
Drug delivery,
catalysis,
imaging
[8]
Pyrogenic
silica (fumed
silica)
Powder Amorphous 2-50 nm primary particles fused to 1-
250 μm aggregates
Void spaces
between primary
particles
Hydrophobic Very
high
Tickner,
performance
additive
[15]
Vitreous
silica (fused
silica glass)
Powder Amorphous 50-2000 μm Dense Hydrophobic
(grinded:
hydrophilic)
Variable Glass [15,19]
Quartz Powder Crystalline 50 nm- several μm Dense Hydrophobic/
(grinded:
hydrophilic)
Variable Geologic
mineral,
Piezoelectricity
[19,20]
Cristobalite Powder Crystalline 1 μm - several cm Dense Hydrophobic Variable Geologic
mineral
[20]
Zeosils
(porosil)
Powder Crystalline 0.05-5000 μm Porous
Pore diameter:
0.4-1.2 nm
Hydrophillic/
hydrophobic
Very
high
Adsorbent [25]
Clathrasils
(porosil)
Powder Crystalline 0.5-5000 μm Porous
Pore diameter:
0.2-0.3 nm
Hydrophillic/
hydrophobic
Very
high
Gas separation [24]
Diatomeus
earth,
kieselguhr
Powder Amorphous,
partially
crystalline
5-120 μm Dense Hydrophillic/
hydrophobic
Low
(90%)
Filter, filling
material
[15]
Figure 3 Electron microscopy images of Stöber silica sol particles (left) and MFI type zeosil (right).
Napierska et al. Particle and Fibre Toxicology 2010, 7:39
http://www.particleandfibretoxicology.com/content/7/1/39
Page 5 of 32silica. The obtained products generally have a broad size
distribution.
Crystalline particles exhibit crystal planes at the sur-
face, and the morphology of the crystalline nanoparticles
depends on the crystal class such as cubic, hexagonal,
tetragonal, and orthorhombic (Figure 3 right). For all
nanomaterials, in aqueous environment, the primary
nano-sized silica particles tend to form aggregates.
Porosity
According to IUPAC [28], pores are classified according
to their diameter into micropores (< 2 nm), mesopores
(2-50 nm) and macropores (> 50 nm). Amorphous sol
particles can be microporous or non-porous (dense).
The porosity of Stöber silica can be tuned by adapting
the synthesis parameters: decreasing the ratio of water
to TEOS promotes particle growth by aggregating smal-
ler sub-particles, thus leading to rough particle surfaces
with micropores. In contrast, smooth particle surfaces
are obtained with conditions of high ratio of water to
TEOS [29]. Silica gel is a powder with particle size in
the micrometer range or larger and is, typically,
mesoporous.
Zeosils and clathrasils have characteristic pores and
cages in the micropore size range, depending on frame-
work topology. Examples of porosil frameworks are
shown in Figure 4 [22].
When the silica is presented as a nanopowder, poros-
ity can be an intrinsic and extrinsic characteristic: sta-
pling of the elementary nanoparticles gives rise to an
interparticle porosity, which often is difficult to distin-
guish from the intrinsic intraparticle porosity, especially
when dealing with mesoporosity.
Hydrophilic-hydrophobic properties
The hydrophilicity of a silica material increases with the
number of silanols, or silicon-bonded hydroxyl groups,
capable of forming hydrogen bonds with physical water
molecules. The chemical formula of silica is represented
as SiO2.xH2O, in which water represents chemical water
contained in silanol groups present on the surface of the
silica material. These water molecules are not to be con-
fused with crystal water, such as that present in many
inorganic salt crystals. The surface chemistry of silica is
depicted in Figure 5. Vicinal hydroxyl groups (one
hydroxyl group per tetrahedron) located at mutual dis-
tances smaller than 3 nm are engaged in hydrogen
bonding. Geminal hydroxyls (2 hydroxyl groups per tet-
rahedron) are considered to occur in minor concentra-
tions. Isolated silanols are positioned too far apart to be
engaged in hydrogen bonding. Because of the differing
chemistry of these 3 types of silanol groups, they are
not all equivalent in their adsorption behavior or chemi-
cal reactivity. Vicinal hydroxyls interact strongly with
water molecules and are responsible for the excellent
water adsorption properties of silica, which are exploited
in industrial gas drying operations, for example.
The reported concentration of hydroxyl groups per
square nanometer on the surface of amorphous silica
ranges from 4 to 5 OH/nm
2 [12]. As compared with
amorphous silica, the crystalline forms of silica generally
contain a lower concentration of surface hydroxyl
groups [15]. Hydrogen-bonded water molecules are
removed when silica is heated at 170°C under atmo-
spheric pressure or at room temperature under vacuum.
Colloidal silica, precipitated silica and ordered meso-
porous silica and silica gel are hydrophilic because of
their high concentration of silanols. Silicagel, for exam-
ple, can adsorb water in quantities up to 100% of its
proper weight.
Porosils typically are hydrophobic because they lack
silanols in the pores of their framework. Silica produced
at high temperature, such as pyrogenic and vitreous
Figure 4 Atomic representation of (left) a zeosil with
microporous channels (MFI type) and (right) clathrasil with a
denser framework (SOD type). Black and gray circles represent
silicon and oxygen atoms, respectively. Figure made with Vesta 2.0.3
[178] with unit cell coordinates from [22].
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Page 6 of 32silica, or calcined at temperatures exceeding 800°C, is
almost entirely dehydroxylated. In a dehydroxylation
reaction, neighboring silanol groups are condensed into
siloxane bonds (Figure 5 bottom) and water molecules.
Some isolated silanol groups may persist on the surface
[15]. Because hydrogen bonding on siloxanes is unfavor-
able, dehydroxylated silica is hydrophobic. Grinding of
hydrophobic bulk materials such as quartz and vitreous
silica induces silicon and oxygen radicals and surface
charges. These charges increase the hydrophilic surface
[19,30].
Solubility
The dissolution and precipitation of silica in water che-
mically involves hydrolysis and condensation reactions,
respectively, catalyzed by OH
- ions (Figure 1).
For micrometer-sized nonporous amorphous silica, the
equilibrium concentrations of Si(OH)4 at 25°C in water
corresponds to 70 ppm at pH 7. The silica solubility
depends on the surface curvature of the (nano)particles.
SNPs and nanoporous silica show enhanced equilibrium
solubility, of 100-130 ppm [12]. According to Vogelsber-
ger et al. [31], the solubilization of amorphous SNPs in
physiological buffer at 25°C is accelerated because of the
large surface area exposed. The solubility equilibrium is
reached only after 24 to 48 h. Crystalline silica such
as quartz has a much lower equilibrium solubility, of
6 ppm [15].
In summary, when dealing with silica, the physico-
chemical properties such as amorphous versus crystal-
line nature, porosity, particle size and degree of hydro-
xylation must be specified. An overview of silica
materials described in the scientific literature and in the
research and development environment is provided in
Table 1.
Toxicity Of Silica
Background
Health effects of silica and epidemiological studies
Until recently, toxicological research into silica particles
focused mainly on “natural” crystalline silica particles of
0.5 to 10 μm (coarse or fine particles). This research
was/is fed by the clear association of occupational inha-
lation exposure and severe health effects, mainly on the
respiratory system. The typical lung reaction induced by
chronic inhalation of crystalline silica is silicosis, a gen-
erally progressive fibrotic lung disease (pneumoconiosis),
exemplified by the development of silicotic nodules
composed of silica particles surrounded by whorled col-
lagen in concentric layers, with macrophages, lympho-
cytes, and fibroblasts in the periphery. Epidemiologic
studies have found that silicosis may develop or progress
even after occupational exposure has ended; therefore,
above a given lung burden of particles, silicosis was sug-
gested to progress without further exposure [32-34].
Calvert et al. [35] recently reported an association of
crystalline silica (mainly quartz) exposure and silicosis,
as well as lung cancer, chronic obstructive pulmonary
disease (COPD), and pulmonary tuberculosis. The carci-
nogenicity of quartz and cristobalite has been shown in
several epidemiological studies [36-38]. In 1997, the
International Agency for Research on Cancer (IARC)
classified some crystalline silica polymorphs (quartz and
cristobalite) in group 1 (sufficient evidence for the carci-
nogenicity to experimental animals and to humans),
whereas amorphous silica (silicon dioxide without crys-
talline structure) was classified in group 3 (inadequate
evidence for carcinogenicity) [39]. This classification has
recently been confirmed [40]. Checkoway and Franzblau
[41] reviewed occupational epidemiologic literature on
the interrelations among silica exposure, silicosis and
lung cancer and concluded that the appearance of silico-
sis is not necessarily required for the development of
silica-associated lung cancer. Hnizdo and Vallyathan
[42] suggested that chronic exposure to levels of crystal-
line silica dust, which does not cause disabling silicosis,
may cause chronic bronchitis, emphysema, and/or small
airway disease leading to airflow obstruction, even in the
absence of radiological evidence of silicosis. Evidence
has linked silica exposure to various autoimmune dis-
eases (systemic sclerosis, rheumatoid arthritis, lupus,
chronic renal disease), as reviewed by Steenland and
Goldsmith [43]. A study by Haustein et al. [44] reported
on silica-induced (silica dust) scleroderma.
Amorphous silica has been far less studied than has
the crystalline form [39]. Warheit [45] briefly described
the inhalation toxicity data related to amorphous silica
particulates and concluded that some forms of amor-
phous silica are more potent in producing pulmonary
effects as compared to others. He also emphasized the
great need for adequate toxicological testing of many of
these amorphous silicates given their importance in
commerce and widespread potential for exposure.
Workers exposed to precipitated or fumed silica did not
exhibit pneumoconiosis [46,47], but evidence of pul-
monary fibrosis was reported in workers exposed to
amorphous silica dust produced as a byproduct of sili-
con metal production [48]. Merget et al. [49] reviewed
the current knowledge of the health effects of a wide
range of amorphous forms of silica in humans. The
major problem in the assessment of health effects of
biogenic amorphous silica is its contamination with
crystalline silica. This problem applies particularly to the
well-documented pneumoconiosis among diatomaceous-
earth workers. Although the data are limited, a risk of
chronic obstructive bronchitis disease, COPD or emphy-
sema cannot be excluded [49]. Animal inhalation studies
involving synthetic amorphous silica (colloidal silica,
fumed silica and precipitated silica) showed at least
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mation and emphysema, but no progressive fibrosis of
the lungs [52,53]. However, high doses of amorphous
silica may result in acute pulmonary inflammatory
responses, which could conceivably trigger long-term
effects, despite a low biopersistence of the particles [54].
The debate on the health effects of micron-sized crystal-
line or amorphous silica is beyond the scope of this
article. Readers are referred to other publications
[35-38,41,55-57].
Mechanisms of toxic action
As mentioned, most of the toxicological research into
silica has focused on crystalline silica particles of 0.5 to
10 μm (coarse or fine particles). Despite the relatively
large amount of available studies, the mechanisms of
crystalline silica toxicity at the cellular and molecular
levels are still unclear, and whether any single mechan-
ism underlies all the above-mentioned diseases induced
by these particles is uncertain [43]. However, severe
inflammation following exposure to silica particles
appears to be a common initiating step [58,59].
The crucial role of reactive oxygen species (ROS) in
the inflammatory, fibrogenic and carcinogenic activity of
quartz is well established [60,61]. Oxidative membrane
and DNA damage are considered the most important
mechanisms involved in the health effects of micron-
sized crystalline silica. A few of the numerous reports
clearly demonstrate these findings: ROS generated by
the silica surface can induce cell membrane damage via
lipid peroxidation that may subsequently lead to
increased cellular permeability [62], perturbation of
intracellular calcium homeostasis [63] and alterations in
signaling pathways. Schins et al. and Fanizza et al.
[64,65] demonstrated that respirable quartz particles
induce oxidative DNA damage in human lung epithelial
cells. Li et al. [66,67] demonstrated that micron-sized
quartz particles induce
.OH generation through an iron-
dependent mechanism. A close association of
.OH and
iron ion concentration has been reported for amorphous
silica particles [66,67]. The study of Ghiazza et al. [30]
indicates that crystallinity might not be a necessary pre-
requisite to make a silica particle toxic; both quartz and
vitreous silica showed stable surface radicals and sus-
tained release of HO
. radicals. When tested on macro-
phages, vitreous silica and pure quartz showed a
remarkable potency in cytotoxicity, release of nitrite and
tumor necrosis factor a (TNF-a) production, suggesting
a common behavior in inducing of oxidative stress [30].
Ding et al. [68] discuss the molecular mechanisms of
silica-induced lung injuries with a focus on NF-kB acti-
vation, generation of cyclooxygenase II and tumor
necrosis factor a (TNF-a). The review of Castranova
[69] summarizes evidence that in vitro and in vivo
exposure to crystalline silica results in activation of
NF-kB and AP-1 signaling pathways. In vitro and in vivo
animal studies, as well as investigations in humans,
strongly support the role of macrophage products in the
development and progression of silicosis [70]. Such pro-
ducts include a large panel of cytokines [71], with TNF-
a seeming to determine the development of silica-
induced pulmonary fibrosis [72]. In addition, recent evi-
dence implicates interleukin 1b (IL-1b) and its activation
by the NALP-3 inflammasome [73].
A large body of experimental work in the past
20 years has shown that 2 main factors seem to govern
the hazardous nature of crystalline silica: particle surface
reactivity and the form of silica [74]. Fenoglio et al. [75]
evaluated these factors systematically, studying synthetic
quartz samples differing only in size and shape. Cyto-
toxicity appeared to be primarily governed by the form
of the particles and the extent of the exposed surface.
Several studies indicate that the surface silanol groups
are directly involved both in membranolysis [76-78] and
in toxicity to alveolar cells [79,80]. Therefore, the distri-
bution and abundance of silanols determines the degree
of hydrophilicity (see “Physico-chemical properties of
synthetic silica materials related to toxicity” described
above) and seems to modulate cell toxicity [80,81].
Experimental work with respirable silica particles and
the survey of published data by Bagchi [82] suggest that
t h et o x i c i t yo ft h e s ep a r t i c l e si sc a u s e db yt h el a r g e
amount of positive charges they carry. Ghiazza et al.
[83] reported that formation of a vitreous phase at the
surface of some commercial diatomaceous earth pre-
vents the onset of oxidative stress effects. Donaldson
and Borm [84] emphasized that the ability of quartz to
generate ROS could be modified by a range of sub-
stances that affect the quartz surface, such as substances
originating from other minerals. The authors concluded
t h a tt h et o x i c i t yo fq u a r t zi sn o tac o n s t a n te n t i t ya n d
may vary greatly depending on the origin/constitution of
the sample.
The origin/synthesis of SNPs plays a crucial role in
determining the physico-chemical properties of these
particles and, consequently, their potential interactions
with biological systems. Surface area, surface morphol-
ogy, surface energy, dissolution layer properties, adsorp-
tion and aggregation properties are relevant parameters.
Depending on the manufacturing process, amorphous
silica has a wide range of physico-chemical properties
that determine its industrial application. Bye et al. [85]
showed that the cytotoxic activity of different forms of
amorphous silica does not depend on a crystalline silica
component but, rather, is caused by surface charges and
the morphologic features of particles. Synthetic amor-
phous silica has been the subject of dissolution testing
with a simulated biological medium, and the silica
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the reverse precipitation rate [86]. Solubility has been
defined as a key driver in the clearance mechanisms
involved in amorphous silica removal from lung [87].
Warheit [45] reviewed pulmonary responses to different
forms of silica and reported that cristobalite produced
the greatest lung injury, quartz produced intermediate
effects, and amorphous silica produced minimal effects.
In terms of analytical technique, small differences in dis-
solution exist among these different forms of silica, and
dissolution, in turn, influences pulmonary effects
through the concept of persistence. In addition, compo-
nents from the biological system may react with the
surface of the particle. A systematic investigation of
iron-containing SNPs as used in industrial fine-chemical
synthesis demonstrated the presence of catalytic activity
that could strongly alter the toxic action of nanoparti-
cles [88].
On the whole, considering the great variety of silica
forms, degree of crystallinity, surface state and the pre-
sence of contaminants, there is a critical need for care-
fully characterized standard silica samples to unravel the
relationships between physico-chemical factors and toxi-
city, both micron- and nano-sized. The main goal of
this review is to focus on the toxicity of nanosilica,
which has never been properly reviewed. Moreover,
nanosilica occurs mainly in amorphous forms, and the
potential hazard posed by these nanomaterials cannot
be simply related to, as has already been reviewed many
times, studies of micron-sized crystalline materials.
Silica nanoparticles
The growing abundance and industrial applications of
nanotechnology has resulted in a recent shift of toxico-
logical research towards nanoparticles [89-94]. Ultrafine
particles (< 0.1 μm) have been demonstrated to cause
greater inflammatory responses and particle-mediated
lung diseases than have fine particles (< 2.5 μm) per
given mass [95-97]. Also, experiments involving silica
have shown that nanoparticles, both ultrafine colloidal
silica [98,99] and crystalline silica [99], have a greater
ability to cause lung injury as compared with fine parti-
cles. Thus, the unique properties (i.e., small size and
corresponding large specific surface area; cell penetrat-
ing ability) of nano-sized SiO2 a r el i k e l yt oi m p o s eb i o -
logical effects that differ greatly from micron-scale
counterparts.
In vitro studies of nanosilica toxicity
A structured summary of in vitro studies of the toxicity
of SNPs can be found in Table 2.
Chen and von Mikecz [100] investigated the effects of
nanoparticles on structure, function, and proteasomal
proteolysis in the cell nucleus by incubating different
cell lines with unlabeled and fluorescently labeled amor-
phous silica particles of different sizes [100]. SiO2 parti-
cles between 40 nm and 5 μm were applied to epithelial
cells in culture and observed on confocal laser scanning
microscopy with differential interference contrast. Parti-
cles of all tested sizes penetrated the cytoplasm; how-
ever, nuclear localization was observed exclusively in
cells treated with SiO2 nanoparticles between 40 and
70 nm. Fine and coarse SiO2 particles (0.2-5 μm) were
exclusively located in the cytoplasm and accumulated
around the nucleus, forming nuclear indentations. The
uptake of SNPs in the nucleus induced aberrant clusters
of topoisomerase I and protein aggregates in the nucleo-
plasm – the former inhibiting replication, transcription,
and cell proliferation – without altering cell viability.
Cells treated with fine (0.5 μm) or coarse (5 μm) SiO2
particles had the same replication and transcription
activity as that of untreated control cells [100].
Jin et al. [101] investigated the potential toxicity of
luminescent amorphous SNPs (50 nm) in freshly iso-
lated rat alveolar macrophage cells and human lung
epithelial cells (A549 cells). The SNPs penetrated the
cells but were not detected in the nuclear region and
did not cause significant toxic effects at the molecular
and cellular levels below a concentration of 0.1 mg/ml.
Lin et al. [102] investigated the cytotoxicity of amor-
phous (colloidal) SNPs (15 and 46 nm) in cultured
human alveolar epithelial cells (A549 cells). Cell viability
decreased in a time- and dose-dependent manner (down
to 100 μg/ml), and nanoparticles of both sizes were
more cytotoxic than were fine quartz particles (Min-U-
Sil 5). Exposure to 15-nm SNPs generated oxidative
stress in A549 cells as reflected by reduced glutathione
(GSH) levels, elevated production of malondialdehyde
(MDA) and lactate dehydrogenase (LDH) leakage, which
is indicative of lipid peroxidation and membrane
damage, respectively [102]. In the study by Wottrich
et al. [103], A549 cells and macrophages (THP-1, Mono
Mac 6) exposed to 60 nm amorphous SNPs showed
distinctly higher mortality than did larger silica particles
(diameter 100 nm). Another study by Choi et al. [104],
involving A549 cells and amorphous SNPs (14 nm),
showed a pro-inflammatory response triggered by nano-
particles without blocking cell proliferation or causing
cell death to any great extent. A recent work by Akhtar
et al. [105] examined cytotoxicity (by MTT and LDH
assay) and oxidative stress (ROS levels, membrane lipid
peroxidation, GSH level and activity of GSH metaboliz-
ing enzymes) in A549 cells exposed for 48 h to amor-
phous SNPs of 10 and 80 nm. The SNPs were cytotoxic
to studied cells through oxidant generation (ROS and
membrane lipid peroxidation) rather than depletion of
GSH. Eom and Choi [106] studied oxidative stress
caused by amorphous SNPs (7 and 5-15 nm) in human
Napierska et al. Particle and Fibre Toxicology 2010, 7:39
http://www.particleandfibretoxicology.com/content/7/1/39
Page 9 of 32Table 2 In vitro studies on nanosilica particles (SNPs) toxicity
Silica form Size (primary) Material characterization Cells used Test Biological endpoints and
findings
Ref
Amorphous 40 nm- 5 μm Not specified A549
HEp-2
RPMI 2650
RLE-6TN
N2a
￿ Replication and
transcription assays
￿ Cell proliferation
and cell viability
assay
￿ Proteasome activity
assay
￿
Immunofluorescence
and microscopy
￿ Uptake of all particles into the
cytoplasm and nuclear
localization of nanoparticles
between 40 and 70 nm
￿ The uptake of NSPs in the
nucleus induced aberrant
clusters of topoisomerase I and
protein aggregates in the
nucleoplasm
[100]
Amorphous
(luminescent)
50 nm ￿ Synthesis (ref. to literature) A549
rat alveolar
macrophages
￿ laser scanning
confocal microscope
￿ Comet Assay
￿ Pulse Field Gel
Electrophoresis
(PFGE)
￿ Western Blot
Analysis of DNA
Adducts/DNA
Agarose Gel
￿ DNA Repair Enzyme
Activity Assay
￿ Cell Proliferation
Assay
￿ Vybrant Apoptosis
Assay
￿ Uptake not detected in the
nuclear region
￿ As compared to the A549
cells, the nanoparticle
penetration rate was much
faster in the rat alveolar
macrophages
￿ No significant toxic effects
observed at the molecular and
cellular levels below a
concentration of 0.1 mg/ml
[101]
Amorphous
(colloidal)
15 and 46 nm ￿ Particle sizes and distribution
￿ Surface area (268 and 52.5
m
2/g for 15 and 46 nm
particle, respectively),
crystalline structure, major
trace metal impurities
￿ Hydrodynamic particle size in
water suspension
A549 ￿ SRB
(sulforhodamine B)
and LDH assays
￿ Reduced
glutathione (GSH)
level
￿ DCFH assay (ROS
generation)
￿ Malondialdehyde
(MDA) assay
￿ Cytotoxicity was dose- and
time-dependent
￿ Reduced glutathione (GSH)
levels and elevated MDA
production after exposure to 15
nm SNPs
[102]
Amorphous 60 and
100 nm
￿ Size distribution analysis
￿ Endotoxin concentration
A549
THP-1
Mono Mac 6;
co-cultures
￿ LDH assay
￿ Cytokine expression
(TNF-a, IL-6, IL-8)
￿ Light and
transmission electron
microscopy (TEM)
￿ Cytotoxicity differed among
the cell lines and was dose-
and size-dependent (smaller
particles were more toxic)
￿ co-cultures showed an
increased sensitivity to particles
concerning the cytokine release
in comparison to the mono-
cultures of each cell type
[103]
Amorphous ~14 nm ￿ Size distribution A549
L-132
HeLa
MNNG/
HOS
￿ MTT and WST-1
assays
￿ Trypan blue
exclusion and LDH
assay
￿ Annexin V-PI assay
(fluorescence
microscopy)
￿ DCFH assay
￿ IL-8 expression
(ELISA)
￿ Little cytotoxic effects in 4 cell
lines tested at the
concentration below 250 μg/ml
within 48 h
￿ Exposing cancer cells to high
concentrations (250-500 μg/ml)
for 72 h resulted in an
inflammatory response with
oxidative stress and membrane
damage, which varied with cell
type (A549>HOS > HeLa)
￿ SNPs triggered an
inflammation response without
causing considerable cell death
for both cancer cells and
normal cells
[104]
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Amorphous 10 and 80 nm o Provided by producer for the
primary particles (surface area:
640 and 440 m
2/g for 10 and
80 nm particle, respectively)
o Hydrodynamic particle size
(in cell culture medium)
A549 ￿ MTT and LDH
assays
￿ DCFH assay
￿ Intracellular
glutathione (GSH)
concentration
￿ Membrane lipid
peroxidation (LPO)
￿ Assay of glutathione
reductase and
glutathione
peoxidase
￿ Cytotoxicity was dose-
dependent
￿ SNPs induced reactive oxygen
species and membrane lipid
peroxidation in dose-dependent
manner
￿ Both sizes of SNPs had little
effect on GSH level and the
activities of glutathione
metabolizing enzymes
[105]
Amorphous 7 and 5-15 nm o Surface area (350 and 644
m
2/g for 7 and 5-15 nm
particle, respectively)
o Size distribution (in the test
medium)
Beas-2B ￿ Incorporation of
SNPs into the cells
(confocal LSM)
￿ MTT assay
￿ PI staining (flow
cytometry)
￿ Apoptosis
￿ DCFH assay
￿ Oxidative stress
responding
transcription factors
(Western blotting)
￿ SNPs were incorporated into
the cells and distributed around
the nucleus area
￿ SNPs induced oxidative stress
via ROS formation and
induction of of antioxidant
enzymes (SOD and HO-1)
￿ Induction of Nrf-2-ERK MAP
kinase signaling pathway was
observed
￿ Overall, cells exposed to 5-15
nm SNPs (porous) showed a
more sensitive response than
those exposed to 7 nm SNPs
(fumed)
[106]
Amorphous 10-20 nm o Provided by manufacturer
(surface area: 140-180 m
2/g)
o Primary particle size
o Endotoxin content (LPS)
A549 ￿ MTT and LDH
assays
￿ DCFH assay
￿ SOD activity
determination
￿ Nitrate/nitrite
determination
￿ DNA oxidative
damage assay
￿ Cytotoxicity was dose- and
time-dependent
￿ SNPs stimulated the ROS
generation, GSH depletion and
lower expression of SOD
activity in a dose-dependent
manner
￿ No NO production and
significant DNA oxidative
damage was observed after
treatment of cells with SNPs
￿ Co-treatment of LPS with
SNPs enhanced observed
cytoxicity and generation of
oxidative stress
[107]
Amorphous 30, 48, 118 and
535 nm
￿ Synthesis method
￿ Hydrodynamic particle size
(in water and cell culture
medium)
HEL-30 ￿ MTT and LDH
assays
￿ Reduced
glutathione (GSH)
and DCFH assay
￿ Transmission
electron microscopy
(TEM)
￿ Cytotoxicity was dose- and
size-dependent (smaller
particles were more toxic)
￿ Uptake of all particles into the
cytoplasm (nuclear uptake not
studied)
￿ GSH level reduced significantly
of after exposure to 30 nm
nanoparticles
￿ No significant Reactive
Oxygen Species (ROS)
formation
[108]
Amorphous 70, 300 and 1000
nm
Not specified XS52 ￿ TEM analysis of cells
￿ LDH assay
￿ Proliferation ([
3H]-
Thymidine
incorporation assay)
￿ SNPs of 300 and 1000 nm
were incorporated into the cells
and located in cytoplasm only;
nanoparticles of 70 nm were
located in nucleus as well as
cytoplasm
￿ Cell proliferation was inhibited
by treatment with SNPs of all
sizes in dose-dependent
manner
￿ The growth of the cells was
more strongly inhibited by
smaller-sized SNPs
[109]
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Amorphous 15, 30 and 365 nm ￿ Size distribution
￿ Zeta potential
￿ Amorphous structure
HaCaT ￿ CCK assay
￿ Cell cycle assay
￿ Annexin V-PI assay
(Flow cytometry)
￿ 2D-DIGE and, IEF
and SDS_PAGE
(protein expression)
￿ Western blot
￿ Cytotoxicity was dose- and
size-dependent (smaller
particles were more toxic)
￿ Apoptosis was dose- and size-
dependent (smaller particles
induced higher apoptosis
frequency)
￿ Up-regulated proteins were
classified as oxidative stress-
associated proteins;
cytoskeleton-associated
proteins; molecular chaperones;
energy metabolism-associated
proteins; apoptosis and tumor-
associated proteins
[110]
Amorphous 15 nm ￿ Size distribution
￿ Zeta potential
￿ Amorphous structure
HaCaT ￿ Flow cytometric
analysis of
methylated DNA
￿ Real-time PCR
￿ Western blot
￿ Treatment with SNPs induced
Global DNA hypomethylation
[111]
Amorphous 21 and 80 nm ￿ Particle preparation and
dispersion
￿ Size, morphology and
chemical states of elements
￿ Hydrodynamic particle size
(dispersed in water)
WS1
CCD-966sk
MRC-5
A549
MKN-28
HT-29
￿ MTT and LDH
assays
￿ Toxicity was seen at
concentrations exceeding 138
μg/ml
￿ Susceptibility to NSPs differed
among tested cell lines
[113]
Amorphous 20 nm Only provided by producer
(surface area: 640 ± 50 m
2/g)
RAW264.7 ￿ Membrane fluidity
measurements (FRAP
technique by LSCM)
￿ DCFH assay
￿ Intracellular free
calcium content
￿ Exposure to SNPs increased
ROS generation and decrease
of the membrane fluidity
￿ Perturbation of Intracellular
free calcium homeostasis was
responsible for observed
cytotoxicity
[114]
Amorphous 14 nm Only provided by producer
(surface area: 200 m
2/g)
Caco-2 ￿ LDH and WST-1
assay
￿ Fpg-modified
comet assay
￿ Total GSH content
￿ Cytotoxicity observed
￿ Oxidative DNA damage
￿ Significant depletion of
intracellular GSH
[115]
Amorphous 21, 48 and 86 nm ￿ Size distribution analysis
￿ Surface area (225, 106 and 39
m
2/g for 21, 48 and 86 nm
particle, respectively)
￿ structure
L-02 ￿ MTT and LDH
assays
￿ TEM assay
￿ DCFH, MDA and
GSH assay
￿ Annexin V-PI assay
(flow cytometry)
￿ DNA ladder assay
￿ Western blot
￿ Cytotoxicity was dose- time -
and size-dependent (smaller
particles were more toxic)
￿ 21 nm SNPs induced ROS
generation, lipid peroxidation
and GSH depletion in a dose-
dependent manner
￿ 21 nm SNPs induced
apoptosis in a dose-dependent
manner
[116]
Amorphous 4-40 nm (mean
size: 14)
Not specified HDMEC ￿ MTS assay
￿ transmission
electron microscopy
(TEM)
￿ Ki67 expression and
IL-8 release
￿ The particles were internalized
but they did not exert cytotoxic
effects
￿ Reduction of the proliferative
activity and a pro-inflammatory
stimulation were observed
[117]
Amorphous
(monodisperse)
14, 15, 16, 19, 60,
104, 335 nm
￿ Particle preparation and
stability
￿ shape and size distribution
￿ surface area (196, 179, 183,
145, 33, 28 and 7.7 m
2/g for
14, 15, 16, 19, 60, 104 and 335
nm particle, respectively)
￿ micropore volume
￿ Hydrodynamic particle size
(in water and cell culture
medium)
EAHY926 ￿ MTT and LDH
assays
￿ Annexin V-PI assay
￿ Cytotoxicity was dose- and
size-dependent (smaller
particles were more toxic and
affected the exposed cells
faster)
￿ Cell death predominantly
caused by necrosis
[118]
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Amorphous 21 and 48 nm ￿ Size distribution analysis
￿ Surface area (225 and 106
m
2/g for 21 and 48 nm
particle, respectively)
￿ structure
H9c2(2-1) ￿ MTT and LDH
assays
￿ Hematoxylin and
eosin staining
￿ DCFH, intracellular
MDA and GSH assays
￿ Flow cytometry (cell
cycle)
￿ Western blot
￿ Cytotoxicity was dose- time -
and size-dependent (smaller
particles were more toxic)
￿ ROS generation in a dose-
dependent manner; increased
level of MDA and decreased
concentration of GSH indicated
oxidative stress
￿ Cell cycle arrest in G1 phase
￿ Dose-dependent expression of
p53 and p21 for 21 nm SNP
[119]
Amorphous From 20 nm to
below 400 nm
￿ the dispersion characteristics
(size, size distribution, size
evolution)
￿ zeta potential
3T3-L1 ￿ comet assay ￿ No detectable genotoxicity
(the results were independently
validated in two separate
laboratories)
[120]
Amorphous
(monodisperse)
16, 60 and 104 nm ￿ Particle preparation and
stability
￿ shape and size distribution
￿ surface area (183, 33 and 28
m
2/g for 16, 60 and 104 nm
particle, respectively)
￿ micropore volume
￿ Hydrodynamic particle size
(in water and cell culture
medium)
A549 ￿ MTT assay
￿ cytochalasin-B
micronucleus assay
(CBMN) alone or in
combination with
FISH-centromeric
staining
￿ Alkaline Comet
assay
￿ Measurements of
cell-associated silica
(ICP-MS)
￿ Results suggest that non-
cytotoxic doses of SNPs may be
capable of inducing slight
chromosome breakage, loss
and mitotic slippage, and at
higher concentration possibly
mitotic arrest.
[122]
Amorphous
(monodisperse)
from 2 up to 335
nm
￿ Particle preparation and
stability
￿ shape and size distribution
￿ surface area (from 232 to 7.7
m
2/g)
￿ micropore volume
￿ Hydrodynamic particle size
(in water and cell culture
medium)
￿ Zeta potential
J774
EAHY926
3T3
Human
erythrocytes
￿ MTT and WST-1
assays
￿ RBC hemolysis
￿ in murine macrophages, the
cytotoxic response, after
treatment with SNPs of 17
different sizes, increased with
external surface area and
decreased with micopore
volume
￿ in human endothelial cells
and mouse embryo fibroblast
the cytotoxicity increased with
surface roughness and decrease
in diameter
￿ the hemolytic activity of SNPs
in human erythrocytes
increased with the diameter of
SNPs
[141]
Amorphous 30 nm ￿ Provided by producer for
primary partilcles (surface area:
165 m
2/g)
￿ Hydrodynamic particle size
(in PBS and cell culture
medium)
￿ Adsorption of proteins from
the test media in the absence
of cells
3T3
hT
RAW264.7
￿ MTS assay
￿ Uptake (flow
cytometry)
￿ DCFH assay
￿ Lysosomal
membrane integrity
￿ Mitochodrial
membrane potential
￿ Apoptosis (caspase-
3, and caspase-7
activation; Annexin V-
PI assay)
￿ SNPs depleted serum proteins
from cell culture media
￿ SNPs cytotoxicity was dose-,
time- and cell line dependent-
dependent
￿ SNPs induced significant ROS
generation in all cell lines
￿ No detectable destabilization
of lysosomal membranes was
observed
￿ Incubation with SNPs
decreased mitochodrial
membrane potential in hT and
RAW cells
￿ SNPs triggered different extent
of cell apoptosis depending on
the cell line tested
[140]
Amorphous
(mesoporous)
110 nm (pore
diameter of ~2.5
nm)
￿ Structure
￿ surface area (910 m
2/g)
￿ pore volume
￿ stability in aqueous solution
3T3-L1
MCF-7
K562
￿ Confocal
microscope
￿ TEM
￿ Flow cytometry
￿ Particles were internalized into
cells and accumulated in
cytoplasm
￿ No apparent cytotoxicity
[123]
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Amorphous
(mesoporous)
Not specified
(MCM-41 particle
type)
￿ Synthesis and
functionalization of particles
￿ Zeta potential
￿ Cylindrical pores with a
diameter around 5 nm
HeLa ￿ MTT, WST-1 and
LDH assays
￿ Flow cytometry for
PI
￿ TEM observations
￿ No cytotoxicity was observed
up to 50 μg/ml
￿ Particles interfered with MTT
assay
[126]
Amorphous
(mesoporous)
108, 110, 111 and
115 nm
￿ Synthesis (ref to the previous
study) and surface
modification
￿ Zeta potential
￿ Surface area (780, 980, 930
and 1050 m
2/g for 108, 110,
111 and 115 nm particle,
respectively)
￿ pore volume and pore size
distribution (2.6-2.0 nm)
hMSCs
3T3-L1
￿ MTT assay
￿ Flow cytometry for
the uptake
￿ Cellular
differentiation and
cytochemical assay
￿ The modulation of surface
charge and its threshold affects
the uptake and is specific to
cell type
￿ Positive correlation of positive
surface charge and the uptake
by the cells
￿ Uptake was through clathrin
and actin-dependent
endocytosis
￿ Uptake did not affect cells
viability, proliferation and
differentiation
[125]
Amorphous
(mesoporous
silica nanorods
capped with
iron oxide NPs)
200 × 80 nm (pore
diameter of ~3
nm)
￿ Preparation and
functionalization
HeLa ￿ Confocal
fluorescence
microscopy
￿ Particles were endocytosed by
the cells and biocompatible
(concentration used: 0.2 mg/
mL)
[127]
Amorphous
(mesoporous)
30, 50, 110, 170
and 280 nm
￿ Synthesis, suspension stability
(no interparticle aggregation),
hydrodynamic diamaters, zeta
potential
HeLa ￿ MTT
￿ onfocal laser
scanning microscopy
￿ ICP-MS
￿ Cellular uptake is highly
particle size-dependent (with
the optimum size of 50 nm);
little cytotoxicity up to 100 mg/
ml
[128]
Amorphous
(mesoporous)
loaded with
anticancer
drugs)
<130 nm (pore
diameter of ~2
nm)
￿ Preparation, shape,
aggregation/stability in
aqueous solution
PANC-1
AsPC-1
Capan-1
MKN45
SW480
￿ Fluorescence and
confocal microscopy
￿ The particles offer the
possibility of controlled release
of anticancer drugs (non-loaded
particles did not caused
cytotoxicity)
[129]
Amorphous
(mesoporous)
150 nm (pore
diameter of ~2.4
nm)
￿ Synthesis, functionalization,
surface area (850 m
2/g), zeta
potential
HeLa ￿ Flow cytometry
￿ Fluorescence
microscopy
￿ Uptake of particles can be
regulated by different surface
functionalization
￿ More negatively charged
particles were able to escape
from endosomes
[130]
Amorphous
(mesoporous)
Commercially
available
amorphous
silica material
100 - 300 nm (pore
diameter of ~3
nm) -
￿ Synthesis (ref. to the previous
study), funcionalization, surface
area (1138 m
2/g), pore
volumes, number of silanol
group
￿ Funcionalization
Rabbit RBCs ￿ Hemolysis assay
￿ UV/Vis spectroscopy
￿ Flow cytometry
￿ The hemolytic activity of silica
nanoparticles depends only on
the concentration of negatively
charged silanol groups
￿ Mesoporous particles exhibit a
high compatibility towards
RBCs as most of the silanols are
located in the interior of the
particles that are not accessible
by the RBCs membranes
[131]
Amorphous
(mesoporous)
300-650 nm (pore
diameter of 31Å)
and SBA-15 type
(>hundreds of nm,
pore diameter of
55 Å)
￿ Synthesis,
￿ Order of mesostructures,
surface area (821 and 506 m
2/
g), wall thickness, composition
HL-60
Jurkat
￿ Oxygen
consumption assay
￿ ATP formation assay
￿ Cellular GSH assay
￿ Particles with larger size and
larger pores caused
concentration- and time
dependent inhibition of cellular
respiration
￿ Both nanoparticles were toxic
to the isolated mitochondria
￿ No significant changes in
cellular glutathione level was
observed
[132]
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Page 14 of 32Table 2 In vitro studies on nanosilica particles (SNPs) toxicity (Continued)
Amorphous
(mesoporous
and silica
nanospheres)
250 nm; 166x320
nm (pore diameter
= 3.5 nm)
￿ Synthesis and
functionalization
￿ Number of particles per
gram, surface area (4.1 and 0.2
m
2/particle for mesoporous
and spherical particle,
respectively)
SK-N-SH ￿ Staining with trypan
blue and
determination of
viable cells using a
hemacytometer
￿ The cytotoxicity of particles
was related to the adsorptive
surface area of the particle (the
most toxic malodorous silica
are those with the largest BET
surface areas)
￿ Dependency of cytotoxicity on
the nature of the attached
functional groups cannot be
ruled out
[133]
Amorphous
(mesoporous)
270 ± 50 nm (pore
diameter of 3.9
nm) and 2.5 μm±
500 nm (pore
diameter of 2.8
nm)
￿ Synthesis
￿ The structural and textural
characterizations
￿ Surface area(520 and 547 m
2/
g for 270 nm and 2.5 μm
particle, respectively)
￿ LPS concentration analysis
Human
monocyte-
derived
dendritic
cells
￿ Apoptosis/necrosis
(Annexin V/PI assay)
￿ production of
cytokinesIL-10 and IL-
12p70,IL-12, IL-10
￿ confocal
microscopy, TEM
￿ Viability, uptake and immune
regulatory markers were
affected with increasing size
and dose
[134]
Amorphous
(mesoporous)
190, 420 and 1220
nm
￿ Synthesis and
functionalization
￿ Size distribution
￿ Dispersity and porosity
￿ Surface area (220-650 m
2/g)
￿ Zeta potential
MDA-MB-468
COS-7
￿ MTT assay
￿ The biodegradation
experiments
￿ Intracellular
localization of
particles
￿ The cytotoxicity of particles
was highly correlated with
particle sizes ((smaller particles
were more toxic)
￿ The biodegradation products
of spherical E-MS particles
showed no toxicity
￿ The residual surfactant bound
to the particles has a much
smaller contribution to the
cytotoxicity than the free one
￿ The smaller particles were
more easily endocytosed and
consequently located within
lysosomes
[135]
Amorphous 100 and 200 nm ￿ rod-shaped and spherical
particles (Stöber), not-coated
and coated with fibronectin or
polyethylene glycol (PEG),
￿ Primary and aggregate size,
surface area (9.2 and 4.6 m
2/g
for silica rods and 27.3 and
14.2 m
2/g for silica spheres),
crystallinity, impurities, zeta
potential
MET-5A ￿ LDH assay
￿ Expression of IL-8
￿ Simulated stretch
imposed on the cells
￿ Dosimetric comparison of
acicular and isotropic
particulate materials is not
straightforward
￿ In the absence of simulated
lung function (stretch), cells
showed no significant
enhancement of cytotoxicity or
inflammation release
￿ PEG surface treatment tended
to reduce the cytotoxicity and
IL-8 release from particle
exposures suggesting the
significance of adhesive
interactions e.g. for membrane
binding/signal transduction
[136]
Amorphous 130 nm and 155
nm; iron oxide
particle with silica
shell (80 nm)
￿ Size distribution
￿ Reference given for the
description in detail
Hmy2
Jurkat
U937
PC3;
human
peripheral
blood cells
￿ MTT assay and
Trypan Blue exclusion
￿ Scanning electron
microscopy
￿ DCFH assay
￿ The cytotoxicity of particles
depended on the cell type
tested
￿ No direct correlation between
ROS production and cell
toxicity.
￿ PEG-ylation of SNP protected
the particles from protein
adsorption on the external
surface of the NPs and
consequently no agglomeration
in culture medium was
observed.
￿ The availability of the particles
to be internalized by the cells
depended on the size and
morphology of the aggregates.
[137]
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Page 15 of 32bronchial epithelial cells (BEAS-2B) and observed the
formation of ROS and induction of antioxidant enzymes.
Shi et al. [107] exposed A549 cells to amorphous
SNPs (10-20 nm) at concentrations up to 200 μg/ml
and observed low cytotoxicity as measured by MTT and
LDH assays. However, co-treatment with the same
nanoparticles and lipopolysaccharide, a bacterial product
that may contaminate (nano)materials, significantly
enhanced the cytotoxicity.
Yu et al. [108] examined the cytotoxic activity (by
MTT and LDH assay) of well-dispersed amorphous
silica particles (30-535 nm) in mouse keratinocytes. All
sizes of particles were taken up into the cell cytoplasm;
nuclear uptake was not studied. The toxicity was dose
and size dependent, with 30- and 48-nm particles being
more cytotoxic than 118- and 535-nm particles. The
reduced GSH level significantly decreased only after
exposure to 30-nm nanoparticles [108]. Nabeshi et al.
[109] showed the size-dependent cytotoxic effects of
amorphous silica particles (70, 300 and 1000 nm) on
mouse epidermal Langerhans cells. The smallest parti-
cles induced greater cytotoxicity (by LDH assay) and
inhibited cellular proliferation (by [
3H]-thymidine incor-
poration). The observed effects were associated with the
quantity of particle uptake into the cells.
Yang et al. [110] evaluated the effects of amorphous
SNPs (15 and 30 nm) and micron-sized silica particles
on cellular viability, cell cycle, apoptosis and protein
expression in the human epidermal keratinocyte cell line
HaCaT. Microscopy examination revealed morphological
changes after 24-h exposure; cell growth also appeared
to be significantly inhibited. The cellular viability of
HaCaT cells was significantly decreased, and the amount
of apoptotic cells was increased in a dose-dependent
manner after treatment with nano- and micron-sized
SiO2 particles. Furthermore, smaller silica particles were
more cytotoxic and induced a higher apoptotic rate.
Proteomic analysis revealed differential induction of
expression of 16 proteins by SiO2 exposure; proteins
were classified into 5 categories according to their func-
tions: oxidative stress-associated proteins, cytoskeleton-
associated proteins, molecular chaperones, energy meta-
bolism-associated proteins, and apoptosis and tumor-
associated proteins. The expression levels of the differ-
entially expressed proteins were associated with particle
size [110]. In a recently published study [111], the same
research group used these SNPs to study the global
DNA methylation profiles in HaCaT cells; the authors
reported that nanosilica treatment can induce epigenetic
changes.
Cousins et al. [112] exposed murine fibroblasts to
small amorphous (colloidal) silica particles (7, 14 and
21 nm) over a long incubation period (1, 3 and 7 days
and up to 7 weeks) and observed a distinctive cellular
response affecting the morphologic features, adhesion
and proliferation of the fibroblasts but not cell viability.
C h a n ge ta l .[ 1 1 3 ]e x p o s e ds e lected human fibroblast
and cancer cell lines for 48 h to amorphous SNPs and
assessed cellular viability by MTT and LDH assays.
Cytotoxicity was seen at concentrations > 138 μg/ml
and depended on the metabolic activity of the cell line.
However, the average primary size of tested silica parti-
cles was 21 and 80 nm, but their average hydrodynamic
particle size was 188 and 236 nm, respectively, so in
media, aggregates/agglomerates were formed.
In the study of Yang et al. [114], cell membrane injury
induced by 20-nm amorphous silica nanoparticles in
mouse macrophages was closely associated with
increased intracellular oxidative stress, decreased mem-
brane fluidity, and perturbation of intracellular calcium
homeostasis.
Besides inhalation, ingestion is considered a major
uptake route of nanoparticles into the human body [3];
however, the possible harmful effects of engineered
nanoparticles in the gastrointestinal tract are still largely
unknown. Recently, Gerloff et al. [115] investigated the
cytotoxic and DNA damaging properties of amorphous
fumed SiO2 nanoparticles (14 nm) in the human colon
epithelial cell-line Caco-2. Exposure to SNPs for up to
24 h caused cell mortality, significant DNA damage and
total glutathione depletion. The results of an in vivo
study of mice fed nanosized silica are discussed in sec-
tion 3.2.2.
Ye et al. [116] reported on induced apoptosis in a
human hepatic cell line after exposure to amorphous
(colloidal) SNPs (21, 48 and 86 nm). The viability of
Table 2 In vitro studies on nanosilica particles (SNPs) toxicity (Continued)
Crystalline Particle sizes not
uniform (7.21, 9.08
and 123.21 nm)
￿ Size and concentration WIL2-NS ￿ MTT assay
￿ Population Growth
Assay
￿ Apoptosis Assay by
Flow Cytometry
￿ Cytokinesis Block
Micronucleus Assay
￿ Comet Assay
￿ HPRT Mutation
Assay
￿ Significant dose-dependent
decrease in viability
￿ with increasing dose of
particles
￿ Fourfold increase in
micronucleated binucleated
cells frequency was detected,
while no significant difference
was measured by the Comet
assay
[99]
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Page 16 of 32Table 3 In vivo studies on nanosilica particles (SNPs) toxicity
Silica
form
Size
(primary)
Material
characterization
Exposure model Test Biological endpoints and
findings
Ref
Quartz 10-20 nm
(average size:
12), 30-65
(average size:
50), 300 nm -
2 μm
￿ Synthesis
￿ Surface area
￿ Crystallinity
￿ Metal
impurities
Rats instilled intratracheally
with various particle types
(1 or 5 mg/kg), sacrificed at
24 h, 1 week, 1 month,
and 3 months post-
exposure
￿ Bronchoalveolar lavage (BAL)
fluid analysis: cell counts,
differentials, and pulmonary
biomarkers (Lactate
dehydrogenase (LDH), alkaline
phosphatase (ALP), and
lavage fluid protein)
￿ Cell proliferation
￿ Morphological/
Histopathology examination
￿ Hemolytic Potential of
particles
Exposures to the various
quartz particles produced
differential degrees of
pulmonary inflammation and
cytotoxicity, which were not
consistent with particle size
but correlated with surface
activity, particularly hemolytic
potential.
[148]
Silica dust 10 ± 5 nm;
and 0.5-10
μm (80% of
the particles
1-5 μm)
￿ Composition
uknown
￿ Surface area
Rats instilled intratracheally
(20 mg), sacrificed 1 and 2
months after dosing
￿ The changes of lung/body
coefficient and
hydroxyproline content
￿ Pathologic examination
￿ Immunohistochemical
staining for IL-4 and TGF-
beta1
One month after instillation
cellular nodules (Stage I
silicosis) were found in the
nanosized SiO2 group, while
in microsized SiO2 group
Stage II, II+ of silicotic
nodules were observed.
Two months after instillation,
still only Stage I silicotic
nodules in nanosilica group
were found, while in the
micro-silica group the disease
progressed and Stage II+, and
III silicotic nodules were
found.
The experiment revealed that
in rats the effect of
fibrogenesis of nano-SiO2
might be milder than that of
micro-SiO2.
[147]
Ludox
colloidal silica
- ￿ Mass median
aerodynamic
diameter (2.9, 3.3
and 3.7 μm)
￿ Chamber
Ludox
concentration
Rats Inhalation (nose-only)
for 2 or 4 weeks at
concentrations 10, 50 and
150 mg/m
3.
Additional groups of rats
exposed for 4 weeks were
given a 3-month recovery
period
￿ Lung silica analysis
￿ BAL analysis: cell differential
counts and biochemical assay
(LDH, ALP, lavage fluid
protein)
￿ Pulmonary macrophage cell
culture and phagocytosis
assay
￿ SEM ananlysis
￿ Additional groups of animals
were processed for cell
labeling studies or lung
deposition studies.
The inflammatory responses,
mainly seen as increased
numbers of neutrophils in
BALF, following the 2 and/or
4 weeks of exposure was
evident at 50 mg/m
3 (or
higher) group. Three months
after exposure most
biochemical parameters
returned to control values.
Results showed that
exposures to 150 mg/m3
Ludox for 2 or 4 weeks
produced pulmonary
inflammation along with
increases in BAL protein, LDH,
and alkaline phosphatase
values (p less than 0.05) and
reduced macrophage
phagocytosis.
Autoradiographic studies
demonstrated that the
labeling indices of terminal
bronchiolar and lung
parenchymal cells were
generally increased in the 50
and 150 mg/m3 groups after
2 and 4 weeks of exposure
but, with one exception,
returned to normal levels
following a 3-month
postexposure period.
[143]
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Page 17 of 32Table 3 In vivo studies on nanosilica particles (SNPs) toxicity (Continued)
Aerosol
containing
colloidal silica
Average size:
22 nm
￿ Mass median
aerodynamic
diameter (2.9, 3.3
and 3.7 μm)
￿ Chamber
Ludox
concentration
Rats inhalation (from 10 to
150 mg/m
3), 6 h/day, 5
days/week for 4 weeks; 3
months postexposure
￿ Lung silica determination
￿ Body weights and clinical
observations
￿ Clinical pathology (urine and
blood samples)
￿ Histopathology
No effects after exposure to
the lowest concentration
Lung weights were increased
significantly after 4 exposure
to 50 and 150 mg/m
3.
A dose dependent alveolar
macrophage response,
polymorphonuclear leukocytic
infiltration, and Type II
pneumocyte hyperplasia in
alveolar duct regions was
reported.
Lung-deposited nanosilica
cleared rapidly from the lungs
with half-times of
approximately 40 and 50 days
for the 50 and 150 mg/m
3
groups, respectively. The
lungs did not show fibrotic
scar tissue formation or
alveolar bronchiolarization.
[52]
Colloidal silica (UFCSs,
average size
of 14 nm)
fine colloidal
silica particles
(FCSs;
average size
of 213 nm)
￿ Size
distribution
￿ Surface area
￿ Metal
composition
Mice instilled intratracheally
(3 mg) and sacrificed 0.5, 2,
6,12 and 24 h after dosing
￿ Histopathology
￿ Immunohistochemistry
￿ Electron microscopy
Histopathological examination
revealed for both sizes
bronchiolar degeneration,
necrosis, neutrophilic
inflammation, alveolar type II
cell swelling and alveolar
macrophage accumulation.
UFCs induced extensive
alveolar hemorrhage, a more
severe bronchiolar epithelial
cell necrosis and neutrophil
influx in alveoli compared to
FCSs.
Electron microscopy
demonstrated UFCSs and
FCSs on bronchiolar and
alveolar wall surface as well
as in the cytoplasm of
alveolar epithelial cells,
alveolar macrophages and
neutrophils.
The findings suggest that
UFCSs (possibly linked to
larger surface area) have
greater ability to induce lung
inflammation and tissue
damages than FCSs.
[98]
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Page 18 of 32Table 3 In vivo studies on nanosilica particles (SNPs) toxicity (Continued)
Colloidal silica average size:
14 nm
￿ Size
distribution
￿ Surface area
￿ Metal
composition
Mice instilled intratracheally
(0.3,3,10,30 or 100 μg) and
sacrificed 3 days after
dosing; 1 to 30 days
postexposure
￿ BAL analysis: cells
quantification, viability and
differentiation, total protein
concentration
￿ Histopathology
￿ Immunohistochemistry
￿ Apoptosis (TUNEL assay)
Exposure up to 100 μgo f
UFCSs produced moderate to
severe pulmonary
inflammation and tissue injury
3 days post exposure.
Mice instilled with 30 μgo f
UFCSs and sacrificed at
intervals from 1 to 30 days
post-exposure showed
moderate pulmonary
inflammation and injury on
BALF indices at acute period;
however, these changes
gradually regressed with time.
Histopathological and
immunohistochemical
examination correlated to
BALF data.
A significant increase of the
apoptotic index (TUNEL) in
lung parenchyma at all
observation times was
reported.
The findings suggest that
instillation of a small dose of
UFCSs caused an acute, but
transient, lung inflammation
and tissue damage in which
oxidative stress and apoptosis
may be involved.
[146]
Amorphous
silica
14 nm ￿ Endotoxins
content
Mice instilled intratracheally
(2,10 and 50 mg/kg) and
sacrificed 24 h, 1,4 and 14
weeks after dosing
￿ BAL analysis: total protein
and endotoxin concentration,
cell differential counts
￿ Histopathology
￿ Real-time PCR
￿ Immunohistochemistry
Significantly increased lung
weights, total BAL cells and
proteins were observed until
1 week after treatment.
Particles induced acute
inflammation (with
neutrophils) at an early stage
and chronic granulomatous
inflammation at the later
stage.
The significant up-regulation
of cytokines (IL-1b, IL-6, IL-8,
and TNF-a) and chemokines
(MCP-1 and MIP-2) was
observed during the early
stages, but there were no
changes after week 1.
In conclusion, Instillation of
nanoparticles induced
transient but very severe lung
inflammation.
[144]
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Page 19 of 32Table 3 In vivo studies on nanosilica particles (SNPs) toxicity (Continued)
Amorphous
silica
37.9 ± 3.3
nm
￿ Size
distribution
￿ Surface area
￿ Particle
number
Rats inhalation (24.1 mg/
m
3, 40 min/day, 4 weeks
The age factor involved 3
levels (young/
adult/old)
￿ Electrocardiography
￿ BAL analysis
￿ Hemorheological analysis
￿ Serum biomarker assay
￿ Pathology
Inhalation of SNP under
identical conditions caused
the strongest pulmonary and
cardi ovascular alterations in
old rats, yet less change in
young and adult rats.
Observed changes included
pulmonary inflammation,
myocardial ischemic damage,
atrio-ventricular blockage, and
increase in fibrinogen
concentration and blood
viscosity.
Old individuals were more
sensitive to nanoparticle
exposure
than the young and adult
rats. The risk of causing
pulmonary
damages was: old > young >
adult. The risk of
cardiovascular disorder was
observed only in old age.
[145]
Amorphous
silica
37 nm and
83 nm
￿ The generation
of nanosilica
aerosol
￿ Size
distribution
Rats inhalation
(3.7 × 10
7 or 1.8 × 10
8
particles/cm
3), 6h/day, for
1- or 3-days
several post-exposure time
points (up to 2 months)
￿ Bal analysis: cell counts,
differentials, enzymatic activity
of LDH,and ALP
￿ Genotoxicity endpoints
(micronuclei induction)
One- or three-day aerosol
exposure produced no
significant pulmonary
inflammatory, genotoxic, or
adverse lung
histopathological effects in
rats exposed to very high
particle numbers
corresponding to a range of
mass concentrations (1.8 or
86 mg/m
3).
[149]
Amorphous
silica
14 nm o Daily mean
mass median
aerodynamic
diameter (2.1 ±
0.1 μm)
Rats inhalation
(head/nose only; 26.9 ± 3
mg/m
3), 6h/day during 6
days);
Challenging the animals by
inhalation to a minimally
irritating concentration of
allergen trimellitic
anhydride (TMA)
￿ Breathing parameters
￿ Cellular and biochemical
changes in BAL
￿ Histopathological airway
changes
Exposure to SNPs alone
resulted in transient changes
in breathing parameters
during exposure, and in nasal
and alveolar inflammation
with neutrophils and
macrophages.
Exposure to particles before a
single TMA challenge resulted
in only a slightly irregular
breathing pattern during TMA
challenge. Pre-exposure to
particles also diminished the
effect of TMA on tidal
volume, laryngeal ulceration,
laryngeal inflammation, and
the number of BAL
eosinophils in most animals.
When the additional group of
animals was exposed to
nanosilica before a second
challenge to TMA, the
pulmonary eosinophilic
infiltrate and edema induced
by a second TMA challenge
in control animals was
diminished by the preceding
silica exposure, but the
number of lymphocytes in
BAL was increased.
[153]
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Amorphous
silica
~30 nm and
~30 μm
￿ Size
distribution
Feeding of mice for 10
weeks (total fed amount of
140 g/kg mice)
￿ Blood analysis
￿ Cytological analysis of lungs
and liver tissue sections
￿ Analysis of silicon in organs
The nano-sized silica particle
dieted group showed higher
value of ALT (alanine
aminotransferase) than
normal and micron-sized silica
dieted groups.
H&E staining of the liver of
the nano-sized particle dieted
group indicated some fatty
liver pattern. The contents of
Si in the livers of the groups
were almost the same.
[154]
Amorphous
silica
(organically
modified)
20-25 nm ￿ Synthesis
￿ Conjugation
with fluorophore
￿ Radiolabelling
Mice injected intravenously
with SPN
(2.0 mg/kg body weight)
￿ Fluorescence imaging (CRi)
￿ MicroPET imaging
￿ Histological Analysis
Greater acummulation of
nanoparticles in liver, spleen
and stomach that in kidney,
heart and lungs.
Almost 100% of the injected
nanoparticles were effectively
cleared out of the animals
over a period of 15 days via
the hepatobiliary excretion.
No signs of organs toxicity
were observed.
[155]
Amorphous
(mesoporous)
silica
150 nm, 800
nm and 4
μm
(pore sizes of
3 nm, 7 nm
and 16 nm)
￿ Synthesis
￿ Size
￿ Endotoxins
content
Rats injected
subcutaneously (30 mg per
rat), Mice injected
intraperitoneally and
intravenously
￿ Hematoxylin and eosin
staining and histological
examination
When the particles were
injected subcutaneously, the
amount of residual material
decreased progressively over
3 months, with good
biocompatibility on histology
at all time points.
Intra-peritoneal and intra-
venous injections in mice
resulted in death or
euthanasia. No toxicity was
seen with subcutaneous
injection of the same particles
in mice.
Microscopic analysis of the
lung tissue of the mice
indicated that death may be
due to thrombosis.
[156]
Amorphous
silica
75, 311 and
830 nm
Not specified Mice injected intravenously
(10-100 mg/kg)
￿ H&E staining; histological
analysis of the liver, kidney,
spleen and lung
￿ Biochemical assays
￿ Gadolinium chloride,
cyclophosphamide and
hepatic hydroxyproline assay
70 nm SNP induced liver
injury at 30 mg/kg body
weight, while SP300 or 1000
had no effect even at 100
mg/kg.
Administration of 70 nm SNP
dose-dependently increased
serum markers of liver injury,
serum aminotransferase and
inflammatory cytokines.
Repeated administration of 70
nm SNP twice a week for 4
weeks, even at 10 mg/kg,
caused hepatic fibrosis.
[157]
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Page 21 of 32cells was assessed by LDH and MTT assay; oxidative
stress was studied by measurement of ROS, lipid peroxi-
dation and GSH concentration; and apoptosis was quan-
tified by annexin V/propidium iodide staining and DNA
ladder assays. Nano-SiO2 caused cytotoxicity in a size-,
dose- and time-dependent manner.
Because nanoparticles are probably distributed by the
blood stream (e.g., with medical applications), endothe-
lial cells would also come in direct contact with these
particles, for pathogenic particle-endothelial interac-
tions. Peters et al. [117] evaluated the effects of 4- to
40-nm amorphous SiO2 particles in vitro on human
dermal microvascular endothelial cell function and via-
bility. The particles were internalized but did not exert
cytotoxic effects (MTS assay). However, cells showed
impaired proliferative activity and pro-inflammatory
stimulation. Napierska et al. [118] reported a dose-
dependent cytotoxicity (by MTT and LDH assay) of
monodisperse amorphous SNPs (16-335 nm) in a
human endothelial cell line. The toxicity of the parti-
cles was strongly related to particle size; smaller parti-
cles showed significantly higher toxicity and also
affected the exposed cells faster. Ye et al. [119] evalu-
ated the toxicity of amorphous SNPs (21 and 48 nm)
towards rat myocardial cells. Exposure to the SNPs for
up to 48 h resulted in size-, dose- and time-dependent
cytotoxicity, smaller particles again showing higher
toxicity.
Barnes et al. [120] reported no detectable genotoxic
activity (by Comet assay) of amorphous SNPs (20 nm
to < 400 nm) in 3T3-L1 fibroblasts at 4 or 40 μg/ml
silica for 24 h. The particle dispersions were carefully
characterized and the results were independently vali-
dated in 2 separate laboratories. In a recent review,
Gonzalez et al. [121], in a literature review, compared 2
genotoxicity tests – t h ea l k a l i n eC o m e ta s s a ya n dt h e
micronucleus test - in terms of chemical composition
and size of engineered SNPs: engineered SNPs did not
seem to induce DNA strand breakage. However, when
monodisperse amorphous SNPs of 3 different sizes (16,
60 and 104 nm) were selected to assess the genotoxic
potential of these particles in A549 lung carcinoma cells
with a well-validated assay (the in vitro cytochalasin-B
micronucleus assay), at non-cytotoxic doses, the smallest
particles showed an apparently higher-fold induction of
micronucleated binucleated (MNBN) cells [122]. When
considering the 3 SNPs together, particle number and
total surface area accounted for MNBN induction
because they were significantly associated with the
amplitude of the effect.
Crystalline nanosilica
Wang et al. [99] investigated cytotoxicity (by MTT
assay) and genotoxicity of ultrafine crystalline SiO2
particulates (UF-SiO2) in cultured human lymphoblas-
toid cells. A 24-h treatment with 120 μg/ml UF-SiO2
produced a fourfold increase in MNBN cells, with no
significant difference as measured by the Comet assay.
However, the ultrafine crystalline silica used was
extracted from commercially available crystalline silica
and the particle sizes were not uniform [99].
Mesoporous silica
The cytoxicity of amorphous mesoporous SNPs
(MSNs) was recently studied intensively because they are
promising materials for drug delivery systems and cell
markers [8,123,124]. Several studies have demonstrated
that efficient cellular uptake of MSNs could be achieved
at concentrations < 50 μg/ml, with no cytotoxic effects
o b s e r v e du pt o1 0 0μg/ml in different mammalian cells
[125-130]. Lu et al. [128] reported on the optimal size of
~50 nm MSNs for cell uptake. Slowing et al. [131]
reported that, contrary to the known cytotoxicity of
amorphous SNPs toward red blood cells, mesoporous
SNPs exhibit high biocompatibility at concentrations
adequate for potential pharmacological applications.
However, studies have reported cytotoxicity of mesopor-
ous silica nanomaterials. Tao et al. [132] investigated the
Table 3 In vivo studies on nanosilica particles (SNPs) toxicity (Continued)
Amorphous
silica
50, 100 and
200 nm
￿ Synthesis
￿ Fluorescence
labeling
Mice injected intravenously
(50 mg/kg)
￿ Confocal laser scanning
microscopy
￿ Immunofluorescence
staining
￿ Fluorescence microplate
readings
Significant increase of
inflammation in the liver at
12 h for the 100 and 200 nm
silica nanoparticles treatment
groups.
The tissue distribution and
excretion of the injected
particles were different
depending on particle size. As
particle sizes increased, more
particles were trapped by
macrophages in the liver and
spleen. All particles were
cleared via urine and bile;
however, the 50 nm silica
nanoparticles excreted faster
than the other two particles.
[158]
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Page 22 of 32effects of two types of MSNs (pore diameters of 31 and 55
Å) on cellular bioenergetics (cellular respiration and ATP
content) in myeloid and lymphoid cells and isolated mito-
chondria. Only cells exposed to MSNs with larger size and
larger pores showed concentration- and time-dependent
inhibition of cellular respiration, and both nanoparticles
were toxic to the isolated mitochondria. Di Pasqua et al.
[133] reported that the toxicity of MSNs towards human
neuroblastoma cells was related to the adsorptive surface
area of the particle. However, the nature of the functional
groups playing a role could not be excluded. Vallhov et al.
[134] investigated the effects of mesoporous SNPs of dif-
ferent sizes (270 nm and 2.5 μm) on human dendritic cells
and found viability, uptake and immune regulatory mar-
kers affected by increasing size and dose. He et al. [135]
evaluated the influence of size and concentration of meso-
porous SNPs (190, 420 and 1220 nm) on cytotoxicity in
human breast cancer cells and monkey kidney cells. The
cytotoxicity of the particles was associated with particle
size: silica of 190 and 420 nm in diameter showed signifi-
cant cytotoxicity at concentrations > 25 μg/ml; whereas
particles of 1220 nm in diameter showed slight cytotoxi-
city at 480 μg/ml. The smaller particles were suggested to
be more easily endocytosed and consequently located
within lysosomes [135].
Surface-modified/functionalized silica
Brown et al. [136] attempted to evaluate the role of
s h a p ei np a r t i c l et o x i c i t yi nt h el u n g ;t h ea u t h o r sc o m -
pared the response of rod-shaped and spherical amor-
phous silica particles (Stöber), not coated or coated
with fibronectin or polyethylene glycol (PEG), under
stretched and static conditions. The dosimetric compari-
son of materials with different shapes (e.g., needle-
shaped or acicular and isotropic) was not straightfor-
ward. Non-coated particles induced an increase in IL-8
and LDH release, whereas a surface modification with
PEG mitigated this effect, which suggested the signifi-
cance of adhesive interactions for membrane binding/
signal transduction, for example [136].
Diaz et al. [137] described the interactions of two
amorphous silica particles - a pristine particle, without
any coating, and PEGylated silica particles (average size
130 and 155 nm), as well as an iron oxide particle with
a silica shell (80 nm) – with different human peripheral
blood cells, several human tumor cell lines and mouse
peritoneal macrophages. The effects depended on the
cell analyzed: although all particles were phagocytosed
a n dw e r ea b l et oi n d u c eR O Se x p r e s s i o ni nm o u s e
macrophages, they differentially affected the human cell
lines and peripheral blood cells, both in terms of inter-
nalization and ROS induction. The availability of the
particles to be internalized by the cells seemed to
strongly depend on aggregation, especially on the size
and morphology of the aggregates [137].
Almost all of the existing cytotoxicity studies of SNPs
involved monocultures of cells that are organ specific.
The exception is the study by Wottrich et al. [103], in
which co-cultures of epithelial cells (A549) and macro-
phages (THP-1, Mono Mac 6) exposed to 60- and 100-
nm amorphous SNPs showed an increased sensitivity to
t h ec y t o k i n er e l e a s ea sc o m p a r e dw i t hm o n o c u l t u r e so f
each cell type. The enhanced responses to nanoparticles
in different contact and non-contact co-cultures were
reported in studies by Herseth et al. [138,139] with
micron-sized crystalline silica, showing that more realis-
tic models should be applied to study interactions
between nanoparticles and cells or organs of interest.
Few recently published studies have systematically
investigated nanomaterial properties in terms of the
degree and pathways of cytotoxicity. Sohaebuddin et al.
[140] selected nanomaterials of different composition,
including silica, to analyze the effects of size and compo-
sition on 3 model cell lines: fibroblasts, macrophages and
bronchiolar epithelial cells. The authors concluded that
the physico-chemical properties of size and composition
both determined the cellular responses and induced cell-
specific responses. In another recent study, Rabolli et al.
[141] studied the influence of size, surface area and
microporosity on the in vitro cytotoxic activity of a set of
17 stable suspensions of monodisperse amorphous
SNPs of different sizes (2-335 nm) in 4 different cell
types (macrophages, fibroblasts, endothelial cells and ery-
throcytes). The response to these nanoparticles was gov-
erned by different physico-chemical parameters that
varied by cell type: in murine macrophages, the cytotoxic
response increased with external surface area and
decreased with micopore volume; in human endothelial
cells and mouse embryo fibroblasts, the cytotoxicity
increased with surface roughness and decrease in dia-
meter; and in human erythrocytes, the hemolytic activity
increased with the diameter of the SNP [141].
Overall, most of these in vitro studies involving differ-
ent SNPs documented the cytotoxic effects of these
nanomaterials. The determinants of the observed cyto-
toxicity seem to be complex and vary with the particles
used and cell type tested. Unfortunately, for many pub-
lished studies, adequate material characterization is still
missing. The mere cytotoxicity reported with some par-
ticles does not strictly imply hazard. However, this
observation indicates that a proactive development of
nanomaterials should consider physical, chemical and
catalytic properties of nanoparticles.
In vivo studies of nanosilica toxicity
Along with particle size, surface area and particle number
appear to be integral components contributing to the
mechanisms of lung toxicity induced by nano-sized parti-
cles. The high deposition rate of ultrafine particulates is a
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be important in the lung inflammatory process. Some evi-
dence suggests that inhaled nanoparticles, after deposition
i nt h el u n g ,l a r g e l ye s c a p ef r o ma l v e o l a rm a c r o p h a g e
clearance and gain greater access to the pulmonary inter-
stitium via translocation from alveolar spaces through
epithelium [3,142]. A summary of the in vivo responses
to SNPs can be found in Table 3.
In 1991, Warheit et al. [143] performed a rat inhala-
tion study (nose-only) with an aerosol of colloidal
silica (mass median aerodynamic diameter 2.9, 3.3 and
3.7 μm) for 2 or 4 weeks at concentrations up to 150
mg/m
3, and some groups of rats were allowed to
recover for 3 months. The inflammatory responses,
mainly seen as increased numbers of neutrophils in
bronchoalveolar lavage fluid (BALF), with the 2 and/or
4 weeks of exposure were evident at ≥ 50 mg/m
3 con-
centration. Three months after exposure, most biochem-
ical parameters returned to control values [143].
Lee and Kelly [52] studied the effects of repeated inha-
lation (6 h/day, 5 days/week for 4 weeks) of an aerosol
of colloidal silica (mass median aerodynamic diameter
2.9, 3.3 and 3.7 μm; concentration up to 150 mg/m
3)i n
rats. The authors reported a dose-dependent alveolar
macrophage response, polymorphonuclear leukocytic
infiltration, and type II pneumocyte hyperplasia in alveo-
lar duct regions. Lung-deposited nanosilica were cleared
rapidly from the lungs, with half-times of approximately
40 and 50 days for the 50 and 150 mg/m
3 treatment
groups, respectively. The lungs did not show formation
of fibrotic scar tissue or alveolar bronchiolarization [52].
Cho et al. [144] investigated inflammatory mediators
(24 h, and 1, 4 or 14 weeks after exposure) induced by
intratracheal instillation in mice of up to 50 mg/kg of
ultrafine amorphous silica with a primary particle dia-
meter of 14 nm. The authors observed significantly
increased lung weights, total cell numbers and levels of
total protein in BALF up to 1 week after treatment. The
histopathological examination revealed acute inflamma-
tion, with neutrophils and chronic granulomatous
inflammation. The expression of cytokines (IL-1b,I L - 6 ,
IL-8, and TNF-a) and chemokines (monocyte chemo-
attractant protein 1 and macrophage inflammatory pro-
tein 2) was significantly increased during the early
stages, with no changes after week 1 [144].
Chen et al. [145] studied age-related differences in
response to amorphous SNPs (average size 38 nm).
Changes in serum biomarkers, pulmonary inflammation,
heart injury and pathology were compared in young
(3 weeks), adult (8 weeks) and old (20 months) rats that
inhaled tested nanoparticles for 4 weeks (40 min/day).
Old animals appeared to be more sensitive to nanoparti-
cle exposure than were young and adult rats. The risk
of pulmonary damage was old > young > adult, but the
risk of cardiovascular disorder was observed only in old
animals [145].
Kaewamatawong et al. [98] compared acute pulmon-
ary toxicity induced in mice by ultrafine colloidal
silica particles (UFCSs; average size 14 nm) or fine
colloidal silica particles (FCSs; average size 213 nm)
after intratracheal instillation of 3-mg particles. Histo-
pathological examination with both sizes revealed
bronchiolar degeneration, necrosis, neutrophilic
inflammation, alveolar type II cell swelling and alveolar
macrophage accumulation. However, UFCSs induced
extensive alveolar hemorrhage, more severe bronchio-
lar epithelial cell necrosis and neutrophil influx in
alveoli as compared with FCSs. Electron microscopy
showed UFCSs and FCSs on the bronchiolar and
alveolar wall surface and in the cytoplasm of alveolar
epithelial cells, alveolar macrophages and neutrophils.
T h ef i n d i n g ss u g g e s tt h a tU F C S s( p o s s i b l yl i n k e dt o
size and/or larger surface area) have a greater ability to
induce lung inflammation and tissue damage than do
FCSs [98]. The same research group reported acute
and subacute pulmonary toxicity of low-dose UFCS
particles in mice after intratracheal instillation [146].
Exposure of up to 100 μg UFCSs produced moderate
to severe pulmonary inflammation and tissue injury 3
days after exposure. Mice instilled with 30 μgU F C S s
and sacrificed at intervals from 1 to 30 days after
exposure showed moderate pulmonary inflammation
and injury on BALF indices at the acute period; how-
ever, these changes gradually regressed with time.
Concomitant histopathological and laminin immuno-
histochemical results were similar to BALF data. The
authors reported a significant increase in the apoptotic
index (TUNEL) in lung parenchyma at all observation
times. The findings suggest that instillation of a small
dose of UFCSs causes acute but transient lung inflam-
mation and tissue damage in which oxidative stress
and apoptosis may be involved [146].
In a study of fibrogenesis, Wistar rats were intratra-
cheally instilled with silica (of unknown composition)
nano- (10 ± 5 nm) and microparticles (0.5-10 μm), and
were sacrificed 1 and 2 months after dosing [147]. One
month after instillation, cellular nodules (Stage I silico-
sis) were found in the nano-sized SiO2 group, whereas
more severe lesions were found in the micron-sized
SiO2 treatment group (Stage II and Stage II+ of silicotic
nodules). One month later, the nano-sized SiO2 group
still showed only Stage I silicotic nodules, whereas the
micron-silica group showed disease progression and
Stage II+ and III silicotic nodules. Therefore, in rats, the
effect of nano-SiO2 on fibrogenesis might be milder
than that of micron-SiO2. Nanoparticles, because of
their size, probably diffuse more easily to other pulmon-
ary compartments than do microparticles [147].
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nanoquartz particles (12 and 50 nm) to mined Min-U-
Sil quartz (500 nm) and synthetic fine-quartz particles
(300 nm) and (2) evaluated the surface activity (hemoly-
tic potential) of the different samples in terms of toxi-
city. Rats were instilled with the different particle types
(1 or 5 mg/kg), and pulmonary toxicity was assessed
with BALF biomarkers, cell proliferation, and histo-
pathological evaluation of lung tissue at 24 h, 1 week,
1m o n t h ,a n d3m o n t h sa f t e re x p o s u r e .E x p o s u r et ot h e
quartz particles of different sizes produced pulmonary
inflammation and cytotoxicity, with nanoscale quartz of
12 nm and Min-U-Sil quartz being more toxic than fine
quartz and nanoscale quartz of 50 nm. The pulmonary
effects were not consistent with particle size but were
associated with surface activity, particularly hemolytic
potential [148].
In a recent work by Sayes et al. [149], rats inhaled
freshly generated aerosolized amorphous SNPs of 37
and 83 nm for a short-term period. In contrast to pre-
vious studies’ measurements, particle number rather
than particle mass was chosen as dose metrics (3.7 ×
10
7 or 1.8 × 10
8 particles/cm
3) for 1- or 3-day exposure.
Pulmonary toxicity (cell counts, differentials, enzymatic
activity of LDH and alkaline phosphatase (ALP) in
BALF) and genotoxicity endpoints (micronuclei induc-
tion) were assessed from 24 h up to 2 months after
exposure. One- or 3-day aerosol exposure produced no
significant pulmonary inflammatory, genotoxic or
adverse lung histopathological effects in rats exposed to
very high particle numbers in a range of mass concen-
trations (1.8 or 86 mg/m
3).
Recently, airway irritants were suggested to facilitate
allergic sensitization [150-152]. Arts et al. [153] exam-
ined the effect of pre-exposure to synthetic (fumed)
amorphous SNPs (14 nm) on elicitation of airway
hypersensitivity reactions by the low-molecular-weight
allergen trimellitic anhydride (TMA). Brown Norway
rats were topically sensitized with TMA, exposed (head
or nose only) to SNPs for 6 h/day for 6 days and then
challenged by inhalation with a minimally irritating con-
centration of TMA. One day later, breathing parameters,
cellular and biochemical changes in BALF, and histo-
pathological airway changes were studied. Exposure to
SNPs alone resulted in transient changes in breathing
parameters during exposure and in nasal and alveolar
inflammation with neutrophils and macrophages. Expo-
sure to particles before a single TMA challenge resulted
in only a slightly irregular breathing pattern during
TMA challenge. Interestingly, pre-exposure to particles
diminished the effect of TMA on tidal volume, laryngeal
ulceration, laryngeal inflammation, and the number of
BALF eosinophils in most animals. When an additional
group of animals was exposed to nanosilica before a
second challenge to TMA, the pulmonary eosinophilic
infiltrate and edema induced by a second TMA chal-
lenge in control animals was diminished by the preced-
ing silica exposure, but the number of lymphocytes in
the BALF was increased. The authors concluded that
SNPs could reduce as well as aggravate certain aspects
of TMA-induced respiratory allergy [153].
As mentioned, next to inhalation, ingestion is consid-
ered a major route for the uptake of nanoparticles in
the human body. So et al. [154] studied the effects on
mice fed nano- and micron-sized amorphous silica par-
ticles (30 nm and approximately 30 μm, respectively).
After feeding the animals for 10 weeks (total amount of
140 g silica/kg mouse), blood was tested biochemically
and hematologically. The group fed SNPs showed higher
serum values of alanine aminotransferase as compared
with the other groups (both control and micron-silica
treated). Although the contents of Si in the livers of the
groups were almost the same, hematoxylin and eosin
staining revealed a fatty liver pattern in the group trea-
ted with SNPs [154].
The successful use of nanoparticles in the clinic
requires exhaustive studies on the behavior of these par-
ticles in vivo. Unfortunately, biocompatibility, biodistri-
bution and clearance studies of silica-based
nanoparticles are sparse. Kumar et al. [155] used nano-
particles of organically modified amorphous silica
(ORMOSIL; amino-terminated; 20-25 nm) to study bio-
distribution, clearance and toxicity in a mouse model.
Particles conjugated with fluorophore and radiolabeled
were injected systemically in mice. Biodistribution stu-
dies showed a greater accumulation of nanoparticles in
liver, spleen and stomach than in kidney, heart and
lungs. Over 15 days, almost 100% of the injected nano-
particles were effectively cleared out of the animals via
hepatobiliary excretion, without any sign of organ toxi-
city. Hudson et al. [156] examined the biocompatibility
of mesoporous silica particles (150 nm, 800 nm and
4 μm) after injection in rats and mice. When the parti-
cles were injected subcutaneously in rats, the amount of
residual material decreased progressively over 3 months,
with no significant injury to surrounding tissues. Subcu-
taneous injection of the same particles in mice produced
no toxic effects. In contrast, intra-peritoneal and intra-
venous injection in mice resulted in death; microscopic
analysis of the lung tissue of the mice indicated that
death might have been due to pulmonary thrombosis.
Nishimori et al. [157] evaluated the acute toxicity of
amorphous silica particles (70, 300 and 1000 nm) after
a single intravenous injection in mice and reported that
70-nm silica injured the liver but not the spleen, lung or
kidney. Moreover, chronic administration of 70-nm
nanoparticles (injections every 3 days for 4 weeks)
caused liver fibrosis. Cho et al. [158] examined the
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sue distribution and excretion. Fluorescence dye-labeled
50-, 100- and 200-nm silica particles were intravenously
injected in mice. The incidence and severity of inflam-
mation with the 100- and 200-nm SNPs was signifi-
cantly increased in the liver at 12 h; the 50-nm particles
induced a slight but nonsignificant inflammatory
response. The tissue distribution and excretion of the
injected particles differed depending on particle size.
With increasing particle size, more particles were
trapped by macrophages in the liver and spleen. All par-
ticles were cleared via urine and bile; however, the 50-
nm SNPs were excreted faster than were the other 2
particle sizes [158].
In vivo versus in vitro; amorphous versus crystalline
Park and Park [159] performed in vitro and in vivo stu-
dies to investigate oxidative stress and pro-inflammatory
responses induced by amorphous SNPs (average pri-
mary size 12 nm). RAW 264.7 cells derived from mouse
peritoneal macrophages were exposed to SNPs (5-40
ppm) in vitro a n ds h o w e dR O Sg e n e r a t i o na n d
decreased intracellular GSH levels, as well as increased
levels of nitric oxide released from the cultured macro-
phage cell line. In vivo, mice were treated with a single
intraperitoneal dose of 50 mg/kg of nanosilica. The
treatment produced activated peritoneal macrophages,
increased blood level of IL-1b and TNF-a, and increased
level of nitric oxide released from peritoneal macro-
phages. Ex vivo, cultured peritoneal macrophages har-
vested from the treated mice showed the expression of
inflammation-related genes (IL-1, IL-6, TNF- a,i n d u c i -
ble nitric oxide synthase, cyclooxygenase 2). In the
spleen, the relative distribution of natural killer cells and
T cells was increased 184.8% and 115.1%, respectively,
as compared with control animals, and that of B cells
was decreased to 87.7% [159].
Kim et al. [160] addressed the toxicity of nano- and
micron-sized silica particles (14 nm and 1-5 μm, respec-
tively) in vitro and in vivo. In vitro, RAW 264.7 cells
were exposed to both particle sizes for 24 h, and the
cell viability was decreased in dose-dependent manner;
however, apoptosis was observed only after treatment
with nanoparticles. In vivo, mice received up to 5 mg/kg
silica particles via oropharyngeal aspiration. Again, size-
dependent toxicity of silica was observed; pulmonary
injury and neutrophilic infiltration were greater after
treatment with nano-sized SiO2 particles than with
micron-sized silica [160].
Sayes et al. [161] assessed the capacity of in vitro
screening studies to predict in vivo pulmonary toxicity of
several fine or nanoscale particle types in rats. For the in
vitro component of the study, rat lung epithelial cells, pri-
mary alveolar macrophages and alveolar macrophages-
lung epithelial cell co-cultures were incubated with
quartz particles and precipitated amorphous silica. In
the in vivo component of the study, rats were exposed by
intratracheal instillation to the same particles. In vivo,
pulmonary toxicity studies demonstrated that crystalline
silica particles produced sustained inflammation and
cytotoxicity, whereas amorphous silica particles produced
reversible and transient inflammatory responses. Ex vivo,
pulmonary inflammation studies showed that crystalline
and amorphous silica-exposed rat lung epithelial cells did
not produce MIP-2 cytokines, but alveolar macrophages
and, to a lesser degree, co-cultures secreted this chemo-
tactic factor into the culture media. In vitro cytotoxicity
studies demonstrated a variety of responses to the differ-
ent particle types, primarily at high doses. When consid-
ering the range of toxicological endpoints, comparisons
of in vivo and in vitro measurements revealed little corre-
lation, particularly when considering the many variables
assessed in this study such as cell types used, culture con-
ditions and time course of exposure, as well as measured
endpoints.
To summarize, extrapolating (or comparing) the results
obtained in vitro to the in vivo situation is difficult and
applies not only to toxicity studies with nanoparticles –
any existing in vitro test system lacks the complexity of
animal models or the human body. However, considering
the number of particles and the number of possible prop-
erties of these particles that may vary (size, shape, coating,
etc.), clearly, not all can be evaluated in in vivo studies,
and scientists have been striving to determine the correla-
tion between the results obtained from in vitro and in vivo
toxicity assessments. Although little correlation has been
found in these studies with nanosilica [159-161], Lu et al.
[162] tested a panel of metal oxide nanoparticles and
could predict the inflammogenicity of tested nanomater-
ials with a battery of simple in vitro tests. Similar conclu-
sions were drawn in a recent study by Rushton et al. [163];
the authors could predict the acute in vivo inflammatory
potential of nanoparticles with cell-free and cellular assays
by using NP surface area-based dose and response metrics.
The authors also found that a cellular component was
required to achieve a higher degree of predictive power.
Established and validated co-culture systems may pro-
vide a tool to better mimic the in vivo system. Using
recently developed 3-D cell cultures and improving the
exposure system (likewise exposure at the air-liquid
interface of a human epithelial airway model reported
by Brandenberger et al. [164]), could substantially
improve the outcome from in vitro studies with
nanomaterials.
Conclusions
Silica or silicon dioxide (SiO2) is, in many forms, abun-
dantly present in our natural environment. The adverse
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ring crystalline silica such as quartz and cristobalite
have been thoroughly documented in occupational set-
tings. Naturally occurring amorphous silica such as dia-
tomaceous earth is considered less harmful. Most of the
synthetic (manufactured) silicas used in a large variety
of applications are amorphous. For silica in general, the
property most significantly linked to the toxicological
potential is the crystallinity. For micron-sized crystalline
silica, oxidative stress and, linked to it, oxidative DNA
and membrane damage, are probably the most impor-
tant mechanisms involved in the inflammogenic and
fibrogenic activities (reviewed by [60]) and/or carcino-
genic activity [39,165], for example. These mechanisms
do not apply to amorphous silica, which has therefore
been far less studied. Moreover, the adverse health
effects of biogenic (natural) amorphous silica is often
attributed to a certain degree of contamination with
crystalline silica [49]. Synthetic amorphous silica (colloi-
dal silica, fumed silica and precipitated silica) is not
involved in progressive fibrosis of the lung [52,53]; how-
ever, high doses of amorphous silica may result in acute
pulmonary inflammatory responses [54].
Interest in using SNPs is growing worldwide, espe-
cially for biomedical and biotechnological applications
such as cancer therapy, DNA transfection, drug delivery,
and enzyme immobilization [5-9]. In general, SNPs are
synthetic, which has an advantage over natural silica in
that they contain fewer or no impurities than do natural
silica, and the physico-chemical properties are known
and well controlled during production. Exposure to
SNPs during the production process and their down-
stream use is probably minimal for sols and gels because
the nanoparticles are trapped/immobilized within their
matrix. However, the inhalation potential of low-density
fumed silica powders or freeze-dried nanoparticles may
be high without adequate precautions.
Results of a growing number of in vitro studies indi-
cate that the particle surface area may play a crucial role
in the toxicity of silica [75,166]. The cytotoxic activity of
silica particles can be related to their surface interfacing
with the biological milieu rather than to particle size or
shape [75]. Surface silanol groups are directly involved
(as shown in vitro) in hemolysis [76-78] and in alveolar
epithelial cell toxicity [79,80]. This observation indirectly
links the hydrophilicity to cellular toxicity [80,81]. The
size and surface physico-chemical features of SNPs con-
tribute decisively to the biological effects of SiO2 nano-
particles. The complexity of protein-SNP interactions
should not be underestimated; these interactions appear
to be affected by the size of SNPs as well [167-171]. The
effect of other physico-chemical properties of SNPs on
health, such as porosity, chemical purity, surface chem-
istry and solubility, are less well studied, and therefore
no definite conclusions can be formulated (summary of
the data can be found in Table 2). Comparison of pub-
lished studies leads to the conclusion that even a small
modification of the surface can result in a more or less
marked change of a biological effect [2,3,172]. Few in
vitro studies have emphasized that the response to SNPs
varies by cell type [137,140,141].
Considering the use of SNPs for medical applications,
biocompatibility and toxicokinetics need to be docu-
mented in great detail because, despite no observation
of acute (cyto)toxicity, the uptake of the particles by
cells may eventually lead to perturbation of intracellular
mechanisms. For instance, the ability of silica-coated
nanomaterials to penetrate the blood-brain barrier sup-
ports the urgent need for extensive studies to clarify the
potential chronic toxicity of these materials [14]. The
successful use of nanoparticles in the clinic requires
exhaustive and elaborate in vivo studies [155]. Of note,
the toxicity of SNPs can depend on not only the mate-
rial itself but also the administration route to the living
body, as was shown by Hudson et al. [156]: subcuta-
neous injection presented good biocompatibility,
whereas intraperitoneal and intravenous injection led to
fatal outcomes.
Unfortunately, only limited short-term and no chronic
in vivo studies of SNPs are available (summary of the
data is found in Table 3), and the current data do not
clarify whether amorphous SNPs - showing augmented
cytotoxicity and presumably processing oxidative DNA
damaging potential – are less or more harmful as com-
pared with micron-sized silica.
Determining the association of results from in vitro
and in vivo toxicity assessments is difficult; however, the
common feature seems to be cytotoxicity and inflamma-
tory response after exposure to SNPs.
To conclude, the available studies of the toxicity of
SNPs are relatively few, especially as compared to the
vast number of studies of titanium dioxide or carbon
nanotubes. Besides the relative lack of information on
the safety or hazards of SNPs, often conflicting evidence
is emerging in the literature as a result of a general lack
of standard procedures, as well as insufficient characteri-
zation of nanomaterials in biological systems. For all
studies, a crucial issue remains the careful, accurate
characterization of particle size and morphologic fea-
tures (especially in the biological media used for experi-
mental set-up), composition, particle surface area and
surface chemistry [173]. Moreover, equally important to
the physico-chemical characterization of the material is
the control of assays and assay conditions [174,175].
Only with the complete description of the NP and assay
can the results of reported studies be comparable
with those of other studies conducted with similar nano-
materials [159,176].
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Page 27 of 32Until now, the health effects of SNPs have mainly
been studied in terms of exposure via the respiratory
tract, after acute or sub-acute exposure; other exposure
routes should also be checked (e.g. blood, skin, gastroin-
testinal tract). Studies of chronicity are needed to sup-
plement and verify the existing data. Information is
insufficient to clearly identify and characterize the health
hazards SNPs pose, and defining the appropriate condi-
tions for safe use of these materials is currently not
possible.
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